Cell	O
type	O
specificity	O
and	O
activation	O
requirements	O
for	O
NFAT-1	B-protein
(	O
nuclear	B-protein
factor	I-protein
of	O
activated	B-cell_type
T-cells	I-cell_type
)	O
transcriptional	O
activity	O
determined	O
by	O
a	O
new	O
method	O
using	O
transgenic	O
mice	O
to	O
assay	O
transcriptional	O
activity	O
of	O
an	O
individual	O
nuclear	B-protein
factor	I-protein
.	O

Nuclear	B-protein
factor	I-protein
of	O
activated	B-cell_type
T-cells	I-cell_type
(	O
NFAT-1	B-protein
)	O
is	O
a	O
transcription	B-protein
factor	I-protein
which	O
is	O
considered	O
to	O
be	O
an	O
important	O
regulator	O
in	O
early	O
T-cell	O
activation	O
.	O

We	O
have	O
developed	O
a	O
system	O
to	O
monitor	O
the	O
transcriptional	O
activity	O
of	O
NFAT-1	B-protein
at	O
the	O
single	O
cell	O
level	O
in	O
whole	O
animals	O
.	O

The	O
system	O
is	O
based	O
on	O
the	O
use	O
of	O
an	O
oligomerized	O
NFAT-1	B-protein
binding	O
motif	O
that	O
directs	O
transcription	B-protein
of	I-protein
SV40	I-protein
T-antigen	I-protein
in	O
transgenic	O
mice	O
.	O

This	O
report	O
represents	O
the	O
first	O
demonstration	O
that	O
a	O
multimerized	O
short	O
binding	O
motif	O
can	O
function	O
appropriately	O
in	O
transgenic	O
mice	O
.	O

NFAT-1	B-protein
activity	O
had	O
previously	O
been	O
thought	O
to	O
be	O
confined	O
to	O
activated	B-cell_type
T-lymphocytes	I-cell_type
upon	O
release	O
of	O
intracellular	B-cell_type
calcium	I-cell_type
.	O

By	O
targeting	O
NFAT-1	B-protein
-dependent	O
gene	O
expression	O
in	O
transgenic	O
mice	O
we	O
discovered	O
new	O
sites	O
of	O
NFAT-1	B-protein
activity	O
.	O

Besides	O
in	O
T-lymphocytes	B-cell_type
NFAT-1	B-protein
activity	O
could	O
also	O
be	O
induced	O
in	O
T-lymphocyte-depleted	B-cell_type
spleen	I-cell_type
cells	I-cell_type
and	O
purified	B-cell_type
B-lymphocytes	I-cell_type
and	O
requires	O
agents	O
that	O
both	O
release	O
intracellular	O
calcium	O
and	O
activate	O
protein	B-protein
kinase	I-protein
C	I-protein
.	O

A	O
difference	O
in	O
the	O
time	O
course	O
of	O
appearance	O
of	O
NFAT-1	B-protein
activity	O
between	O
T-lymphocytes	B-cell_type
and	O
non-T-lymphocytes	B-cell_type
was	O
revealed	O
.	O

Constitutive	O
expression	O
was	O
observed	O
in	O
a	O
small	O
population	O
of	O
cells	O
in	O
the	O
dermis	O
and	O
some	O
mice	O
have	O
developed	O
skin	O
lesions	O
.	O

Interestingly	O
,	O
the	O
tissue	O
pattern	O
of	O
expression	O
of	O
the	O
NFAT-1	B-protein
activity	O
resembles	O
the	O
expression	O
pattern	O
described	O
for	O
HIV-LTR/tat	O
transgenic	O
mice	O
(	O
Vogel	O
,	O
J.	O
,	O
Hinrichs	O
,	O
S.	O
H.	O
,	O
Reynolds	O
,	O
R.	O
K.	O
,	O
Luciw	O
,	O
P.	O
A.	O
,	O
and	O
Jay	O
,	O
G.	O
(	O
1988	O
)	O
Nature	O
335	O
,	O
606-611	O
)	O
.	O

This	O
similarity	O
in	O
expression	O
and	O
the	O
fact	O
that	O
NFAT-1	B-protein
has	O
been	O
shown	O
to	O
bind	O
functional	B-DNA
sequences	I-DNA
in	O
HIV-LTR	B-DNA
suggest	O
a	O
role	O
for	O
NFAT-1	B-protein
in	O
dermal	O
activation	O
of	O
the	O
HIV-LTR	B-DNA
.	O

THz	NULL
Journat	NULL
or	NULL
BroLocicaL	NULL
CHEemistRy	NULL
©1990	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

265	NULL
,	NULL
No	NULL
.	NULL

26	NULL
,	NULL
Issue	NULL
of	NULL
September	NULL
15	NULL
,	NULL
pp	NULL
.	NULL

15788-15795	NULL
,	NULL
1990	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Cell	NULL
Type	NULL
Specificity	NULL
and	NULL
Activation	NULL
Requirements	NULL
for	NULL
NFAT-1	NULL
(	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T-cells	NULL
)	NULL
Transcriptional	NULL
Activity	NULL
Determined	NULL
by	NULL
a	NULL
New	NULL
Method	NULL
Using	NULL
Transgenic	NULL
Mice	NULL
to	NULL
Assay	NULL
Transcriptional	NULL
Activity	NULL
of	NULL
an	NULL
Individual	NULL
Nuclear	NULL
Factor*	NULL
{	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
April	NULL
12	NULL
,	NULL
1990	NULL
)	NULL
Cornelis	NULL
L.	NULL
Cynthia	NULL
Guidos§	NULL
,	NULL
and	NULL
Gerald	NULL
R.	NULL
Crabtree	NULL
From	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
and	NULL
§Department	NULL
of	NULL
Pathology	NULL
,	NULL
Beckman	NULL
Center	NULL
,	NULL
Stanford	NULL
University	NULL
Medical	NULL
School	NULL
,	NULL
Stanford	NULL
,	NULL
California	NULL
94305	NULL
Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T-cells	NULL
(	NULL
NFAT-1	NULL
)	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
which	NULL
is	NULL
considered	NULL
to	NULL
be	NULL
an	NULL
important	NULL
regulator	NULL
in	NULL
early	NULL
T-cell	NULL
activation	NULL
.	NULL

We	NULL
have	NULL
developed	NULL
a	NULL
system	NULL
to	NULL
monitor	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NFAT-1	NULL
at	NULL
the	NULL
single	NULL
cell	NULL
level	NULL
in	NULL
whole	NULL
animals	NULL
.	NULL

The	NULL
system	NULL
is	NULL
based	NULL
on	NULL
the	NULL
use	NULL
of	NULL
an	NULL
oligomerized	NULL
NFAT-1	NULL
binding	NULL
motif	NULL
that	NULL
directs	NULL
transcription	NULL
of	NULL
SV40	NULL
T-antigen	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

This	NULL
report	NULL
represents	NULL
the	NULL
first	NULL
demonstration	NULL
that	NULL
a	NULL
multimerized	NULL
short	NULL
binding	NULL
motif	NULL
can	NULL
function	NULL
appropriately	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

NFAT-1	NULL
activity	NULL
had	NULL
previously	NULL
been	NULL
thought	NULL
to	NULL
be	NULL
confined	NULL
to	NULL
activated	NULL
T-lymphocytes	NULL
upon	NULL
release	NULL
of	NULL
intracellular	NULL
calcium	NULL
.	NULL

By	NULL
targeting	NULL
NFAT-1-dependent	NULL
gene	NULL
expression	NULL
in	NULL
transgenic	NULL
mice	NULL
we	NULL
discovered	NULL
new	NULL
sites	NULL
of	NULL
NFAT-1	NULL
activity	NULL
.	NULL

Besides	NULL
in	NULL
T-lymphocytes	NULL
NFAT-1	NULL
activity	NULL
could	NULL
also	NULL
be	NULL
induced	NULL
in	NULL
T-lymphocyte-depleted	NULL
spleen	NULL
cells	NULL
and	NULL
purified	NULL
B-lymphocytes	NULL
and	NULL
requires	NULL
agents	NULL
that	NULL
both	NULL
release	NULL
intracellular	NULL
calcium	NULL
and	NULL
activate	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
.	NULL

A	NULL
difference	NULL
in	NULL
the	NULL
time	NULL
course	NULL
of	NULL
appearance	NULL
of	NULL
NFAT-1	NULL
activity	NULL
between	NULL
T-lymphocytes	NULL
and	NULL
non-T-lymphocytes	NULL
was	NULL
revealed	NULL
.	NULL

Constitutive	NULL
expression	NULL
was	NULL
observed	NULL
in	NULL
a	NULL
small	NULL
population	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
dermis	NULL
and	NULL
some	NULL
mice	NULL
have	NULL
developed	NULL
skin	NULL
lesions	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
tissue	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
NFAT-1	NULL
activity	NULL
resembles	NULL
the	NULL
expression	NULL
pattern	NULL
described	NULL
for	NULL
HIV-LTR/tat	NULL
transgenic	NULL
mice	NULL
(	NULL
Vogel	NULL
,	NULL
J.	NULL
,	NULL
Hinrichs	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Reynolds	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
Luciw	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Jay	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
335	NULL
,	NULL
606-611	NULL
)	NULL
.	NULL

This	NULL
similarity	NULL
in	NULL
expression	NULL
and	NULL
the	NULL
fact	NULL
that	NULL
NFAT-1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
functional	NULL
sequences	NULL
in	NULL
HIV-LTR	NULL
suggest	NULL
a	NULL
role	NULL
for	NULL
NFAT-1	NULL
in	NULL
dermal	NULL
activation	NULL
of	NULL
the	NULL
HIV-LTR	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
a	NULL
gene	NULL
is	NULL
generally	NULL
believed	NULL
to	NULL
be	NULL
determined	NULL
by	NULL
nuclear	NULL
factors	NULL
that	NULL
interact	NULL
with	NULL
specific	NULL
cis-elements	NULL
in	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
for	NULL
reviews	NULL
see	NULL
Ptashne	NULL
,	NULL
1988	NULL
;	NULL
Mitchell	NULL
and	NULL
Tjian	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
regulatory	NULL
regions	NULL
or	NULL
enhancers	NULL
contain	NULL
,	NULL
in	NULL
most	NULL
cases	NULL
,	NULL
a	NULL
combination	NULL
of	NULL
*	NULL
These	NULL
studies	NULL
were	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
HL	NULL
33942	NULL
and	NULL
CA	NULL
39612	NULL
(	NULL
to	NULL
G.	NULL
R.	NULL
C.	NULL
)	NULL
and	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
CA	NULL
42551	NULL
(	NULL
to	NULL
Irving	NULL
Weissman	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

{	NULL
Recipient	NULL
of	NULL
EMBO	NULL
Long-term	NULL
Fellowship	NULL
ALTF	NULL
117-1987	NULL
.	NULL

Present	NULL
address	NULL
:	NULL
Central	NULL
Laboratory	NULL
of	NULL
the	NULL
Netherlands	NULL
Red	NULL
Cross	NULL
Blood	NULL
Transfusion	NULL
Service	NULL
,	NULL
Plesmanlaan	NULL
125	NULL
,	NULL
1066	NULL
CX	NULL
Amsterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
.	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

binding	NULL
sites	NULL
for	NULL
different	NULL
transcriptional	NULL
activators	NULL
.	NULL

The	NULL
observed	NULL
tissue	NULL
or	NULL
cell	NULL
type	NULL
specificity	NULL
might	NULL
be	NULL
the	NULL
outcome	NULL
of	NULL
the	NULL
combinatorial	NULL
action	NULL
of	NULL
different	NULL
distinct	NULL
factors	NULL
or	NULL
determined	NULL
by	NULL
a	NULL
distinct	NULL
tissue-	NULL
or	NULL
cell	NULL
type-specific	NULL
factor	NULL
like	NULL
the	NULL
pituitary-specific	NULL
factor	NULL
Pit-1	NULL
(	NULL
or	NULL
GHF-1	NULL
)	NULL
for	NULL
the	NULL
cell-specific	NULL
expression	NULL
of	NULL
growth	NULL
hormone	NULL
and	NULL
prolactin	NULL
(	NULL
Nelson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T-cells	NULL
(	NULL
NFAT-1	NULL
)	NULL
'	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
involved	NULL
in	NULL
regulation	NULL
of	NULL
the	NULL
gene	NULL
for	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
and	NULL
is	NULL
considered	NULL
to	NULL
be	NULL
an	NULL
important	NULL
regulator	NULL
in	NULL
early	NULL
T-cell	NULL
activation	NULL
(	NULL
Shaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Synthesis	NULL
of	NULL
IL-2	NULL
is	NULL
restricted	NULL
to	NULL
T-cells	NULL
and	NULL
is	NULL
regulated	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
(	NULL
Fujita	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Siebenlist	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

The	NULL
IL-2	NULL
gene	NULL
is	NULL
controlled	NULL
by	NULL
a	NULL
267-bp	NULL
enhancer	NULL
extending	NULL
from	NULL
-52	NULL
to	NULL
-319	NULL
containing	NULL
all	NULL
the	NULL
information	NULL
for	NULL
T-cell-specific	NULL
inducible	NULL
activation	NULL
of	NULL
IL-2	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
(	NULL
Fujita	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Siebenlist	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Durand	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

This	NULL
enhancer	NULL
contains	NULL
a	NULL
combination	NULL
of	NULL
different	NULL
protein	NULL
binding	NULL
motifs	NULL
and	NULL
several	NULL
nuclear	NULL
proteins	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
its	NULL
regulation	NULL
.	NULL

NFAT-1	NULL
binds	NULL
the	NULL
sequence	NULL
between	NULL
-263	NULL
and	NULL
-290	NULL
in	NULL
the	NULL
IL-2	NULL
enhancer	NULL
(	NULL
Durand	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Shaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
NFAT-1	NULL
or	NULL
a	NULL
NFAT-1	NULL
like	NULL
factor	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
functional	NULL
sequences	NULL
in	NULL
the	NULL
HIV-LTR	NULL
(	NULL
Shaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
is	NULL
not	NULL
only	NULL
tissue-specific	NULL
but	NULL
also	NULL
strictly	NULL
dependent	NULL
on	NULL
induction	NULL
.	NULL

Binding	NULL
of	NULL
ligands	NULL
to	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
in	NULL
association	NULL
with	NULL
the	NULL
proper	NULL
histocompatibility	NULL
molecules	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
antigen-pre-senting	NULL
cells	NULL
underlies	NULL
the	NULL
physiological	NULL
triggering	NULL
for	NULL
T-cell	NULL
activation	NULL
and	NULL
IL-2	NULL
production	NULL
.	NULL

The	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
interaction	NULL
can	NULL
be	NULL
bypassed	NULL
by	NULL
using	NULL
a	NULL
calcium	NULL
ionophore	NULL
,	NULL
ionomycin	NULL
,	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
phorbol	NULL
ester	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
which	NULL
provide	NULL
an	NULL
increase	NULL
in	NULL
intracellular	NULL
calcium	NULL
and	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
respectively	NULL
(	NULL
Wiskocil	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Weiss	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
;	NULL
Truneh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Imboden	NULL
and	NULL
Stobo	NULL
,	NULL
1985	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
studies	NULL
using	NULL
a	NULL
panel	NULL
of	NULL
different	NULL
cell	NULL
lines	NULL
have	NULL
shown	NULL
that	NULL
NFAT-1	NULL
binding	NULL
and	NULL
transcriptional	NULL
activity	NULL
can	NULL
only	NULL
be	NULL
detected	NULL
in	NULL
human	NULL
and	NULL
murine	NULL
T-cell	NULL
lines	NULL
after	NULL
stimulation	NULL
via	NULL
the	NULL
T-cell	NULL
receptor	NULL
or	NULL
with	NULL
agents	NULL
that	NULL
release	NULL
intracellular	NULL
calcium	NULL
(	NULL
Shaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Crabtree	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

As	NULL
for	NULL
IL-2	NULL
mRNA	NULL
transcription	NULL
the	NULL
induction	NULL
of	NULL
NFAT-1	NULL
transcriptional	NULL
activity	NULL
is	NULL
specifically	NULL
blocked	NULL
by	NULL
the	NULL
immunosuppressive	NULL
drug	NULL
cyclosporin	NULL
A	NULL
(	NULL
Em-	NULL
'The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
NFAT-1	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T-cells	NULL
;	NULL
IL-2	NULL
,	NULL
interleukin	NULL
2	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
ConA	NULL
,	NULL
concanavalin	NULL
A	NULL
;	NULL
Hepes	NULL
,	NULL
4-	NULL
(	NULL
2-hydroxyethyl	NULL
)	NULL
-1-piperazineethanesul-fonic	NULL
acid	NULL
;	NULL
FACS	NULL
,	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
;	NULL
HIV-LTR	NULL
,	NULL
human	NULL
immunodeficiency	NULL
virus-long	NULL
terminal	NULL
repeat	NULL
.	NULL

15788	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san§	NULL
4q	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
duy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
NFAT-1	NULL
Transcriptional	NULL
Activity	NULL
in	NULL
Transgenic	NULL
Mice	NULL
mel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
NFAT-1	NULL
is	NULL
a	NULL
T-cell-specific	NULL
inducible	NULL
transcription	NULL
factor	NULL
that	NULL
responds	NULL
to	NULL
calcium-mediated	NULL
signals	NULL
initiated	NULL
at	NULL
the	NULL
T-cell	NULL
receptor	NULL
and	NULL
accounts	NULL
for	NULL
the	NULL
T-cell	NULL
specificity	NULL
of	NULL
IL-2	NULL
expression	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
we	NULL
have	NULL
developed	NULL
a	NULL
system	NULL
to	NULL
assay	NULL
for	NULL
NFAT-1	NULL
transcriptional	NULL
activity	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Transgenic	NULL
mice	NULL
provide	NULL
a	NULL
unique	NULL
model	NULL
for	NULL
determining	NULL
the	NULL
sequences	NULL
of	NULL
a	NULL
gene	NULL
which	NULL
are	NULL
required	NULL
for	NULL
inducible	NULL
cell	NULL
type-specific	NULL
expression	NULL
of	NULL
that	NULL
gene	NULL
.	NULL

Such	NULL
a	NULL
model	NULL
offers	NULL
the	NULL
possibility	NULL
to	NULL
test	NULL
the	NULL
activity	NULL
of	NULL
NFAT-1	NULL
in	NULL
every	NULL
cell	NULL
in	NULL
vivo	NULL
.	NULL

Oligomers	NULL
of	NULL
a	NULL
number	NULL
of	NULL
binding	NULL
sites	NULL
for	NULL
individual	NULL
transcription	NULL
factors	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
transcription	NULL
from	NULL
a	NULL
heterologous	NULL
promoter	NULL
in	NULL
transient	NULL
expression	NULL
systems	NULL
in	NULL
a	NULL
manner	NULL
which	NULL
reflects	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
factors	NULL
that	NULL
bind	NULL
these	NULL
sequences	NULL
(	NULL
Angel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Durand	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Pierce	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

To	NULL
date	NULL
this	NULL
approach	NULL
has	NULL
not	NULL
been	NULL
applied	NULL
to	NULL
transgenic	NULL
animals	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
have	NULL
used	NULL
NFAT	NULL
binding	NULL
sites	NULL
to	NULL
direct	NULL
expression	NULL
of	NULL
SV40	NULL
T-antigen	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Evidence	NULL
is	NULL
presented	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
transgene	NULL
is	NULL
indicative	NULL
for	NULL
NFAT-1	NULL
transcriptional	NULL
activity	NULL
.	NULL

This	NULL
approach	NULL
has	NULL
allowed	NULL
an	NULL
unambiguous	NULL
analysis	NULL
of	NULL
the	NULL
activation	NULL
requirements	NULL
and	NULL
cell	NULL
type	NULL
specificity	NULL
of	NULL
NFAT-1	NULL
transcriptional	NULL
activity	NULL
.	NULL

The	NULL
similarity	NULL
in	NULL
the	NULL
expression	NULL
pattern	NULL
between	NULL
the	NULL
NFAT-1/SV40	NULL
T-antigen	NULL
mice	NULL
and	NULL
the	NULL
HIV-LTR/tat	NULL
mice	NULL
(	NULL
Vogel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
suggests	NULL
a	NULL
role	NULL
for	NULL
NFAT	NULL
-1	NULL
in	NULL
HIV-LTR	NULL
activation	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Plasmid	NULL
Construction	NULL
and	NULL
Microinjection-A	NULL
plasmid	NULL
was	NULL
made	NULL
by	NULL
fusion	NULL
of	NULL
the	NULL
XAhol	NULL
site	NULL
at	NULL
position	NULL
-294	NULL
from	NULL
the	NULL
internal	NULL
deletion	NULL
mutant	NULL
ILs6	NULL
to	NULL
the	NULL
Xhol	NULL
site	NULL
at	NULL
position	NULL
-72	NULL
in	NULL
the	NULL
deletion	NULL
mutant	NULL
ILs22	NULL
(	NULL
Durand	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

This	NULL
plasmid	NULL
,	NULL
lacking	NULL
222	NULL
bp	NULL
of	NULL
the	NULL
IL-2	NULL
enhancer/promoter	NULL
region	NULL
(	NULL
-319	NULL
to	NULL
+47	NULL
)	NULL
fused	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
,	NULL
was	NULL
linearized	NULL
with	NULL
Xhol	NULL
and	NULL
the	NULL
ends	NULL
were	NULL
phosphatased	NULL
and	NULL
filled	NULL
in	NULL
by	NULL
Klenow	NULL
polymerase	NULL
.	NULL

Multiple	NULL
copies	NULL
of	NULL
the	NULL
double-stranded	NULL
NFAT	NULL
-1	NULL
oligonucleotide	NULL
were	NULL
ligated	NULL
in	NULL
this	NULL
site	NULL
.	NULL

Prior	NULL
to	NULL
addition	NULL
of	NULL
the	NULL
blunt-ended	NULL
vector	NULL
to	NULL
the	NULL
ligation	NULL
reaction	NULL
the	NULL
oligonucleotides	NULL
were	NULL
allowed	NULL
to	NULL
self-ligate	NULL
for	NULL
3	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
cloning	NULL
in	NULL
Escherichia	NULL
coli	NULL
,	NULL
plasmids	NULL
containing	NULL
0-6	NULL
copies	NULL
of	NULL
the	NULL
NFAT-1	NULL
binding	NULL
site	NULL
were	NULL
obtained	NULL
.	NULL

Copy	NULL
number	NULL
and	NULL
orientation	NULL
of	NULL
the	NULL
NFAT-1	NULL
binding	NULL
sites	NULL
were	NULL
determined	NULL
by	NULL
enzyme	NULL
digestion	NULL
analysis	NULL
and/or	NULL
sequencing	NULL
(	NULL
Sanger	NULL
et	NULL
cal	NULL
.	NULL

,	NULL
1977	NULL
)	NULL
.	NULL

The	NULL
NFAT-Tag	NULL
and	NULL
ATag	NULL
transgenes	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
were	NULL
constructed	NULL
by	NULL
replacing	NULL
a	NULL
HindIII-BamHI	NULL
fragment	NULL
containing	NULL
the	NULL
CAT	NULL
gene	NULL
in	NULL
the	NULL
construct	NULL
with	NULL
and	NULL
without	NULL
NFAT-1	NULL
binding	NULL
sites	NULL
,	NULL
respectively	NULL
,	NULL
with	NULL
the	NULL
SV40	NULL
T-antigen	NULL
gene	NULL
,	NULL
assembled	NULL
from	NULL
a	NULL
404-bp	NULL
HindIII-BstXI	NULL
and	NULL
a	NULL
2234-bp	NULL
BstXI-BamHI	NULL
fragment	NULL
derived	NULL
from	NULL
viral	NULL
SV40	NULL
DNA	NULL
.	NULL

Linear	NULL
DNA	NULL
fragments	NULL
containing	NULL
the	NULL
transgenes	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
vector	NULL
with	NULL
ClaI	NULL
and	NULL
HindIII	NULL
,	NULL
separated	NULL
on	NULL
low	NULL
melting	NULL
point	NULL
agarose	NULL
gels	NULL
,	NULL
and	NULL
isolated	NULL
by	NULL
means	NULL
of	NULL
Elutip-d	NULL
column	NULL
elution	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
)	NULL
.	NULL

DNA	NULL
was	NULL
diluted	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
4	NULL
ug/ml	NULL
and	NULL
injected	NULL
into	NULL
pronuclei	NULL
of	NULL
fertilized	NULL
eggs	NULL
obtained	NULL
from	NULL
C57B1/6	NULL
females	NULL
and	NULL
reimplanted	NULL
in	NULL
pseudopregnant	NULL
C129	NULL
females	NULL
(	NULL
Hogan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

Genomic	NULL
DNA	NULL
isolated	NULL
from	NULL
tail	NULL
segments	NULL
of	NULL
the	NULL
offspring	NULL
was	NULL
used	NULL
to	NULL
identify	NULL
transgenic	NULL
mice	NULL
by	NULL
Southern	NULL
blot	NULL
and/or	NULL
dot	NULL
blot	NULL
analysis	NULL
.	NULL

Transgene	NULL
sequences	NULL
were	NULL
revealed	NULL
by	NULL
hybridization	NULL
with	NULL
a	NULL
nick-translated	NULL
SV40	NULL
T-antigen	NULL
probe	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Transfection-The	NULL
human	NULL
Jurkat	NULL
T	NULL
cell	NULL
leukemia	NULL
line	NULL
,	NULL
702/3	NULL
and	NULL
Ly1*	NULL
B-cell	NULL
lines	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
(	NULL
Gibco	NULL
)	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
100	NULL
units/ml	NULL
penicillin	NULL
,	NULL
and	NULL
0.1	NULL
mg/ml	NULL
streptomycin	NULL
.	NULL

Transfection	NULL
of	NULL
Jurkat	NULL
cells	NULL
by	NULL
DEAE-dextran	NULL
was	NULL
done	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Durand	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

At	NULL
40	NULL
h	NULL
after	NULL
transfection	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
as	NULL
indicated	NULL
with	NULL
ionomycin	NULL
(	NULL
500	NULL
ng/ml	NULL
)	NULL
or	NULL
anti-T3	NULL
(	NULL
C305	NULL
,	NULL
1/10,000	NULL
)	NULL
(	NULL
Weiss	NULL
and	NULL
Stobo	NULL
,	NULL
1984	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
for	NULL
assay	NULL
of	NULL
CAT	NULL
expression	NULL
8	NULL
h	NULL
after	NULL
stimulation	NULL
(	NULL
Gorman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1982	NULL
)	NULL
.	NULL

Cell	NULL
Preparation-Spleen	NULL
and/or	NULL
thymus	NULL
were	NULL
removed	NULL
aseptically	NULL
from	NULL
6-8-week-old	NULL
mice	NULL
immediately	NULL
after	NULL
cervical	NULL
dislocation	NULL
and	NULL
prepared	NULL
as	NULL
single	NULL
cell	NULL
suspensions	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
at	NULL
2	NULL
x	NULL
10°	NULL
cells/ml	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
(	NULL
Gibco	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
50	NULL
uM	NULL
2-mercaptoethanol	NULL
,	NULL
100	NULL
units/ml	NULL
penicillin	NULL
,	NULL
and	NULL
0.1	NULL
mg/ml	NULL
streptomycin	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
as	NULL
indicated	NULL
with	NULL
ionomycin	NULL
(	NULL
500	NULL
ng/ml	NULL
)	NULL
,	NULL
ConA	NULL
(	NULL
6	NULL
ug/ml	NULL
)	NULL
,	NULL
or	NULL
anti-CD3	NULL
15789	NULL
(	NULL
145-2C11	NULL
,	NULL
2	NULL
ug/ml	NULL
)	NULL
(	NULL
Leo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
cyclosporin	NULL
A	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
was	NULL
added	NULL
at	NULL
this	NULL
time	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
at	NULL
different	NULL
time	NULL
periods	NULL
after	NULL
stimulation	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
.	NULL

T-cells	NULL
were	NULL
removed	NULL
from	NULL
splenocytes	NULL
by	NULL
incubating	NULL
10°	NULL
cells/ml	NULL
with	NULL
anti-Thy-1.2	NULL
(	NULL
42-21	NULL
)	NULL
in	NULL
Hanks	NULL
'	NULL
buffered	NULL
salt	NULL
solution	NULL
,	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.0	NULL
,	NULL
and	NULL
2	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

Cells	NULL
were	NULL
subsequently	NULL
pelleted	NULL
through	NULL
1	NULL
ml	NULL
of	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
resuspended	NULL
in	NULL
TC199	NULL
medium	NULL
(	NULL
Gibco	NULL
)	NULL
with	NULL
agarose-preabsorbed	NULL
complement	NULL
(	NULL
%	NULL
)	NULL
and	NULL
100	NULL
ug/ml	NULL
DNase	NULL
I	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
45	NULL
min	NULL
at	NULL
38	NULL
°C	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
contaminating	NULL
CD3-positive	NULL
cells	NULL
was	NULL
less	NULL
than	NULL
2	NULL
%	NULL
after	NULL
one	NULL
round	NULL
of	NULL
elimination	NULL
as	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
carried	NULL
out	NULL
on	NULL
a	NULL
highly	NULL
modified	NULL
dual	NULL
laser	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
FACS	NULL
IV	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
made	NULL
available	NULL
through	NULL
the	NULL
Stanford	NULL
shared	NULL
users	NULL
group	NULL
.	NULL

About	NULL
90	NULL
%	NULL
of	NULL
the	NULL
remaining	NULL
cells	NULL
were	NULL
B-cells	NULL
.	NULL

Pure	NULL
splenic	NULL
B-	NULL
and	NULL
T-cell	NULL
populations	NULL
were	NULL
obtained	NULL
by	NULL
incubation	NULL
with	NULL
fluorescein-conjugated	NULL
RA3-6B2	NULL
(	NULL
anti-6B220	NULL
)	NULL
and	NULL
53-2.1	NULL
(	NULL
anti-Thy-1.2	NULL
)	NULL
monoclonal	NULL
antibodies	NULL
,	NULL
respectively	NULL
.	NULL

Positive	NULL
cells	NULL
were	NULL
im-munomagnetically	NULL
selected	NULL
and	NULL
then	NULL
further	NULL
purified	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
(	NULL
Guidos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

This	NULL
two-step	NULL
procedure	NULL
yielded	NULL
B	NULL
or	NULL
T	NULL
populations	NULL
of	NULL
greater	NULL
than	NULL
99.5	NULL
%	NULL
purity	NULL
when	NULL
re-analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
and	NULL
sorting	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
highly	NULL
modified	NULL
dual	NULL
laser	NULL
FACS	NULL
IV	NULL
.	NULL

RNA	NULL
Analyses-Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
various	NULL
tissues	NULL
and	NULL
cultured	NULL
cells	NULL
by	NULL
the	NULL
guanidium	NULL
thiocyanate	NULL
(	NULL
Chirgwin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1979	NULL
)	NULL
and	NULL
hot	NULL
phenol	NULL
extraction	NULL
(	NULL
Verweij	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
procedures	NULL
,	NULL
respectively	NULL
.	NULL

RNA	NULL
was	NULL
quantitated	NULL
by	NULL
spectrophotometry	NULL
at	NULL
260	NULL
nm	NULL
.	NULL

RNA	NULL
mapping	NULL
experiments	NULL
with	NULL
the	NULL
Sp6/T7	NULL
RNA	NULL
polymerase	NULL
system	NULL
were	NULL
done	NULL
according	NULL
to	NULL
Melton	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
10	NULL
ug	NULL
of	NULL
RNA/analysis	NULL
were	NULL
used	NULL
,	NULL
unless	NULL
otherwise	NULL
noted	NULL
,	NULL
which	NULL
was	NULL
verified	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
after	NULL
electrophoresis	NULL
of	NULL
5	NULL
%	NULL
of	NULL
the	NULL
sample	NULL
.	NULL

For	NULL
the	NULL
mapping	NULL
of	NULL
correctly	NULL
initiated	NULL
NFAT	NULL
-Tag	NULL
mRNA	NULL
a	NULL
Sp6	NULL
RNA	NULL
probe	NULL
was	NULL
transcribed	NULL
from	NULL
EcoRI-digested	NULL
pSP65IL-2	NULL
containing	NULL
a	NULL
117-bp	NULL
Xhol-HindIII	NULL
fragment	NULL
from	NULL
-70	NULL
to	NULL
+47	NULL
of	NULL
NFAT-Tag	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
probe	NULL
generates	NULL
a	NULL
47-nucleotide	NULL
RNase-resistant	NULL
fragment	NULL
after	NULL
hybridization	NULL
to	NULL
correctly	NULL
initiated	NULL
NFAT	NULL
Tag	NULL
transcripts	NULL
.	NULL

Hybridization	NULL
was	NULL
allowed	NULL
to	NULL
proceed	NULL
at	NULL
42	NULL
°C	NULL
for	NULL
16	NULL
h	NULL
and	NULL
samples	NULL
were	NULL
digested	NULL
with	NULL
4	NULL
ug/ml	NULL
RNase	NULL
A	NULL
and	NULL
160	NULL
units/	NULL
ml	NULL
RNase	NULL
T1	NULL
at	NULL
30	NULL
°C	NULL
for	NULL
1	NULL
h.	NULL
For	NULL
mapping	NULL
of	NULL
the	NULL
murine	NULL
IL-2	NULL
RNAs	NULL
the	NULL
riboprobe	NULL
was	NULL
synthesized	NULL
from	NULL
the	NULL
T7	NULL
promoter	NULL
of	NULL
the	NULL
HindIII-digested	NULL
pCD-IL-2	NULL
plasmid	NULL
,	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Frank	NULL
Lee	NULL
(	NULL
DNAX	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
containing	NULL
the	NULL
900-bp	NULL
murine	NULL
IL-2	NULL
Pst	NULL
[	NULL
-Acel	NULL
cDNA	NULL
fragment	NULL
(	NULL
Yokota	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
.	NULL

This	NULL
probe	NULL
generates	NULL
a	NULL
400-nucleotide	NULL
RNase-resistant	NULL
fragment	NULL
after	NULL
hybridization	NULL
to	NULL
murine	NULL
IL-2	NULL
mRNA	NULL
.	NULL

Protected	NULL
fragments	NULL
were	NULL
electrophoresed	NULL
on	NULL
5	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
exposed	NULL
to	NULL
XAR-5	NULL
film	NULL
.	NULL

Immunofluorescence-Spleen	NULL
cells	NULL
were	NULL
cultured	NULL
and	NULL
10°	NULL
cells	NULL
were	NULL
pelleted	NULL
on	NULL
a	NULL
microscope	NULL
slide	NULL
by	NULL
cytospin	NULL
centrifugation	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
fixed	NULL
for	NULL
5	NULL
min	NULL
in	NULL
methanol	NULL
at	NULL
-20	NULL
°C	NULL
followed	NULL
by	NULL
30	NULL
s	NULL
in	NULL
acetone	NULL
at	NULL
-20	NULL
°C	NULL
.	NULL

The	NULL
fixed	NULL
samples	NULL
were	NULL
treated	NULL
with	NULL
fluorescein	NULL
isothiocyanate-conjugated	NULL
anti-Tag	NULL
monoclonal	NULL
antibody	NULL
PB1Q01	NULL
(	NULL
Gurney	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1980	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
supplemented	NULL
with	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
2	NULL
%	NULL
)	NULL
and	NULL
then	NULL
washed	NULL
3	NULL
times	NULL
in	NULL
phosphate-buffered	NULL
saline/2	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
and	NULL
examined	NULL
under	NULL
a	NULL
fluorescence	NULL
microscope	NULL
.	NULL

Skin	NULL
tissue	NULL
was	NULL
dipped	NULL
in	NULL
Tissue-Tek	NULL
OCT	NULL
embedding	NULL
medium	NULL
(	NULL
Miles	NULL
)	NULL
,	NULL
frozen	NULL
in	NULL
dry	NULL
CO	NULL
;	NULL
,	NULL
stored	NULL
at	NULL
-70	NULL
°C	NULL
,	NULL
and	NULL
sectioned	NULL
at	NULL
-20	NULL
°C	NULL
onto	NULL
microscope	NULL
slides	NULL
.	NULL

Fixation	NULL
and	NULL
staining	NULL
were	NULL
done	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Nuclear	NULL
Extracts-Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
essentially	NULL
as	NULL
described	NULL
by	NULL
Ohlsson	NULL
and	NULL
Edlund	NULL
(	NULL
1986	NULL
)	NULL
.	NULL

Nuclear	NULL
proteins	NULL
were	NULL
finally	NULL
precipitated	NULL
with	NULL
90	NULL
%	NULL
saturated	NULL
(	NULL
NH	NULL
,	NULL
)	NULL
;	NULL
SO	NULL
,	NULL
and	NULL
dissolved	NULL
in	NULL
50	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
.	NULL

Binding	NULL
reactions	NULL
contained	NULL
3	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
,	NULL
25	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
75	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmeth-ylsulfonyl	NULL
]	NULL
fluoride	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
1.5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
about	NULL
5000	NULL
cpm	NULL
of	NULL
a	NULL
**P	NULL
NFAT	NULL
oligonucleotide	NULL
probe	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
15	NULL
ul	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
702/83	NULL
and	NULL
5B2.1	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
before	NULL
(	NULL
Shaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
and	NULL
10	NULL
ug	NULL
was	NULL
used	NULL
per	NULL
binding	NULL
assay	NULL
.	NULL

The	NULL
assay	NULL
for	NULL
DNA-protein	NULL
complexes	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Shaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Fried	NULL
and	NULL
Crothers	NULL
,	NULL
1981	NULL
)	NULL
.	NULL

RESULTS	NULL
Construction	NULL
of	NULL
NFAT-1/SV40	NULL
T-antigen	NULL
Hybrid	NULL
Gene-Regulatory	NULL
transcription	NULL
units	NULL
were	NULL
designed	NULL
consisting	NULL
of	NULL
0-6	NULL
copies	NULL
of	NULL
the	NULL
30-bp	NULL
NFAT-1	NULL
binding	NULL
sequence	NULL
linked	NULL
to	NULL
the	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san§	NULL
4q	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
duy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
15790	NULL
IL-2	NULL
promoter	NULL
region	NULL
(	NULL
-70	NULL
to	NULL
+47	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
portion	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
is	NULL
not	NULL
responsive	NULL
to	NULL
T-cell	NULL
activation	NULL
signals	NULL
and	NULL
has	NULL
little	NULL
or	NULL
no	NULL
activity	NULL
in	NULL
transfection	NULL
studies	NULL
(	NULL
Fujita	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Durand	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Serfling	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Williams	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Initially	NULL
,	NULL
these	NULL
units	NULL
were	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
to	NULL
test	NULL
their	NULL
T-cell-specific	NULL
inducible	NULL
activation	NULL
of	NULL
transcription	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Inducibility	NULL
of	NULL
CAT	NULL
activity	NULL
was	NULL
observed	NULL
for	NULL
the	NULL
constructs	NULL
harboring	NULL
two	NULL
or	NULL
more	NULL
copies	NULL
of	NULL
the	NULL
NFAT-1	NULL
sequence	NULL
upon	NULL
stimulation	NULL
via	NULL
the	NULL
T-cell	NULL
receptor	NULL
,	NULL
whereas	NULL
the	NULL
level	NULL
of	NULL
activation	NULL
of	NULL
transcription	NULL
seemed	NULL
to	NULL
reach	NULL
a	NULL
maximum	NULL
for	NULL
the	NULL
constructs	NULL
with	NULL
three	NULL
to	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
NFAT-1	NULL
binding	NULL
sequence	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
mode	NULL
of	NULL
activation	NULL
of	NULL
these	NULL
constructs	NULL
are	NULL
in	NULL
accord	NULL
with	NULL
that	NULL
required	NULL
for	NULL
NFAT-1	NULL
binding	NULL
and	NULL
transcriptional	NULL
activity	NULL
described	NULL
previously	NULL
in	NULL
that	NULL
it	NULL
is	NULL
active	NULL
in	NULL
T-cells	NULL
stimulated	NULL
through	NULL
the	NULL
antigen	NULL
receptor	NULL
or	NULL
with	NULL
agents	NULL
that	NULL
increase	NULL
intracellular	NULL
calcium	NULL
(	NULL
calcium	NULL
is	NULL
felt	NULL
to	NULL
be	NULL
an	NULL
essential	NULL
mediator	NULL
of	NULL
signals	NULL
initiated	NULL
at	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
)	NULL
(	NULL
Shaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Durand	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

To	NULL
prepare	NULL
the	NULL
transgene	NULL
,	NULL
designated	NULL
NFAT	NULL
we	NULL
used	NULL
the	NULL
plasmid	NULL
containing	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
30-bp	NULL
NFAT-1	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
CAT	NULL
gene	NULL
was	NULL
replaced	NULL
by	NULL
the	NULL
SV40	NULL
T-antigen	NULL
(	NULL
Tag	NULL
)	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
a	NULL
similar	NULL
construct	NULL
without	NULL
the	NULL
NFAT-1	NULL
binding	NULL
sites	NULL
,	NULL
designated	NULL
ATag	NULL
,	NULL
was	NULL
prepared	NULL
.	NULL

The	NULL
transgenes	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
vector	NULL
,	NULL
puri-fied	NULL
,	NULL
and	NULL
injected	NULL
into	NULL
fertilized	NULL
C57BI/6J	NULL
eggs	NULL
(	NULL
Hogan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
.	NULL

Four	NULL
founder	NULL
transgenic	NULL
mice	NULL
with	NULL
NFAT	NULL
called	NULL
Tag8	NULL
,	NULL
Tag9	NULL
,	NULL
Tagl1	NULL
,	NULL
and	NULL
Tag23	NULL
,	NULL
and	NULL
five	NULL
mice	NULL
with	NULL
the	NULL
ATag	NULL
control	NULL
gene	NULL
,	NULL
called	NULL
A38	NULL
,	NULL
A52	NULL
,	NULL
A83	NULL
,	NULL
A94	NULL
,	NULL
and	NULL
A96	NULL
,	NULL
were	NULL
pro-duced	NULL
.	NULL

Eight	NULL
of	NULL
these	NULL
founder	NULL
mice	NULL
were	NULL
successfully	NULL
bred	NULL
to	NULL
produce	NULL
stable	NULL
lines	NULL
of	NULL
transgenic	NULL
mice	NULL
containing	NULL
approximately	NULL
4	NULL
(	NULL
line	NULL
8	NULL
)	NULL
,	NULL
20	NULL
(	NULL
line	NULL
9	NULL
)	NULL
,	NULL
20	NULL
(	NULL
line	NULL
11	NULL
)	NULL
,	NULL
1	NULL
{	NULL
line	NULL
23	NULL
)	NULL
,	NULL
10	NULL
(	NULL
line	NULL
A52	NULL
)	NULL
,	NULL
>	NULL
20	NULL
(	NULL
line	NULL
A83	NULL
)	NULL
,	NULL
5	NULL
(	NULL
line	NULL
A94	NULL
)	NULL
,	NULL
and	NULL
1	NULL
(	NULL
line	NULL
A95	NULL
)	NULL
copy	NULL
per	NULL
genome	NULL
.	NULL

Only	NULL
one	NULL
transgenic	NULL
founder	NULL
,	NULL
A38	NULL
,	NULL
was	NULL
sterile	NULL
.	NULL

Tissue	NULL
Distribution	NULL
of	NULL
NFAT-Tag	NULL
Transgene	NULL
Expression-To	NULL
determine	NULL
where	NULL
the	NULL
NFAT	NULL
transgene	NULL
was	NULL
expressed	NULL
in	NULL
these	NULL
transgenic	NULL
mice	NULL
,	NULL
tissues	NULL
were	NULL
taken	NULL
from	NULL
a	NULL
second	NULL
generation	NULL
mouse	NULL
of	NULL
each	NULL
transgenic	NULL
line	NULL
and	NULL
analyzed	NULL
for	NULL
Q	NULL
”	NULL
x	NULL
s	NULL
OW	NULL
a	NULL
IL-2	NULL
enhancer	NULL
GGAGGaAAAACTGTTTCATACAGAAGGCGT	NULL
_	NULL
,	NULL
GaAA	NULL
2	NULL
,	NULL
fould	NULL
pge	NULL
NFAT-Tag	NULL
transgene	NULL
wees	NULL
_	NULL
protected	NULL
fragment	NULL
47n	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
functional	NULL
sequences	NULL
within	NULL
the	NULL
IL-2	NULL
enhancer	NULL
and	NULL
structure	NULL
of	NULL
the	NULL
NFAT-Tag	NULL
transgene	NULL
.	NULL

The	NULL
IL-2	NULL
flanking	NULL
region	NULL
including	NULL
the	NULL
enhancer	NULL
and	NULL
promoter	NULL
is	NULL
represented	NULL
by	NULL
a	NULL
bar	NULL
(	NULL
-319	NULL
to	NULL
+47	NULL
)	NULL
.	NULL

The	NULL
open	NULL
boxes	NULL
within	NULL
the	NULL
IL-2	NULL
enhancer	NULL
indicate	NULL
regions	NULL
which	NULL
are	NULL
protected	NULL
from	NULL
digestion	NULL
by	NULL
DNase	NULL
I	NULL
(	NULL
NFIL-2A	NULL
,	NULL
-65/-94	NULL
;	NULL
AP-1	NULL
,	NULL
-177/-184	NULL
,	NULL
NF-kB/AP-3	NULL
,	NULL
-~188/-208	NULL
;	NULL
NFIL-2A	NULL
,	NULL
-234/-259	NULL
;	NULL
and	NULL
NFAT-1	NULL
,	NULL
-257/	NULL
-286	NULL
)	NULL
,	NULL
and	NULL
have	NULL
been	NULL
identified	NULL
as	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
indicated	NULL
factors	NULL
based	NULL
on	NULL
studies	NULL
using	NULL
the	NULL
purified	NULL
proteins	NULL
and	NULL
cross-com-petition	NULL
studies	NULL
(	NULL
Serfling	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Nabel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Jung	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Brunvand	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
K.	NULL
S.	NULL
Ullman	NULL
,	NULL
C.	NULL
A.	NULL
Edwards	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
initiation	NULL
site	NULL
of	NULL
transcription	NULL
.	NULL

The	NULL
NFAT	NULL
-Tag	NULL
transgene	NULL
contains	NULL
successively	NULL
the	NULL
sequence	NULL
-319	NULL
to	NULL
-283	NULL
of	NULL
the	NULL
IL-2	NULL
enhancer	NULL
,	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
NFAT	NULL
-1	NULL
binding	NULL
site	NULL
,	NULL
the	NULL
IL-2	NULL
promoter	NULL
sequence	NULL
from	NULL
~70	NULL
to	NULL
+47	NULL
,	NULL
and	NULL
the	NULL
SV40	NULL
T-antigen	NULL
gene	NULL
.	NULL

Transcribed	NULL
RNA	NULL
is	NULL
indicated	NULL
underneath	NULL
the	NULL
corresponding	NULL
gene	NULL
sequences	NULL
.	NULL

The	NULL
176-nucleotide	NULL
(	NULL
n	NULL
)	NULL
Sp6	NULL
antisense	NULL
RNA	NULL
probe	NULL
used	NULL
in	NULL
RNase	NULL
protection	NULL
experiments	NULL
contains	NULL
the	NULL
IL-2	NULL
enhancer	NULL
sequence	NULL
from	NULL
-70	NULL
to	NULL
+47	NULL
and	NULL
60	NULL
nucleotides	NULL
of	NULL
pSP	NULL
polylinker	NULL
sequences	NULL
(	NULL
open	NULL
bar	NULL
)	NULL
.	NULL

Correctly	NULL
initiated	NULL
mRNA	NULL
would	NULL
yield	NULL
a	NULL
47-nucleotide	NULL
protected	NULL
fragment	NULL
.	NULL

NFAT-1	NULL
Transcriptional	NULL
Activity	NULL
in	NULL
Transgenic	NULL
Mice	NULL
correctly	NULL
initiated	NULL
SV40	NULL
T-antigen	NULL
mRNA	NULL
by	NULL
RNase	NULL
protection	NULL
.	NULL

As	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
the	NULL
176-nucleotide	NULL
RNA	NULL
probe	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
is	NULL
complementary	NULL
to	NULL
47	NULL
nucleotides	NULL
of	NULL
the	NULL
expected	NULL
5	NULL
end	NULL
of	NULL
the	NULL
NFAT	NULL
mRNA	NULL
.	NULL

Therefore	NULL
,	NULL
hybridization	NULL
of	NULL
the	NULL
probe	NULL
to	NULL
correctly	NULL
initiated	NULL
transcripts	NULL
should	NULL
yield	NULL
a	NULL
47-bp	NULL
hybrid	NULL
after	NULL
RNase	NULL
digestion	NULL
.	NULL

Results	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
are	NULL
from	NULL
studies	NULL
with	NULL
a	NULL
mouse	NULL
from	NULL
line	NULL
Tag8	NULL
.	NULL

Correctly	NULL
initiated	NULL
transcripts	NULL
were	NULL
detected	NULL
in	NULL
thymus	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
bone	NULL
marrow	NULL
cells	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
.	NULL

Unexpectedly	NULL
,	NULL
we	NULL
also	NULL
detected	NULL
transcripts	NULL
in	NULL
skin	NULL
without	NULL
induction	NULL
.	NULL

The	NULL
remaining	NULL
tissues	NULL
including	NULL
bladder	NULL
,	NULL
fat	NULL
,	NULL
unstimulated	NULL
spleen	NULL
,	NULL
unstimulated	NULL
thymus	NULL
,	NULL
brain	NULL
,	NULL
intes-tine	NULL
,	NULL
testis	NULL
,	NULL
liver	NULL
,	NULL
kidney	NULL
,	NULL
lung	NULL
,	NULL
muscle	NULL
,	NULL
heart	NULL
,	NULL
parotid	NULL
,	NULL
stom-ach	NULL
,	NULL
pancreas	NULL
,	NULL
and	NULL
unstimulated	NULL
bone	NULL
marrow	NULL
cells	NULL
did	NULL
not	NULL
express	NULL
detectable	NULL
levels	NULL
of	NULL
NFAT	NULL
mRNA	NULL
.	NULL

We	NULL
observed	NULL
a	NULL
difference	NULL
in	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
between	NULL
the	NULL
different	NULL
lines	NULL
.	NULL

Two	NULL
lines	NULL
,	NULL
Tagl1	NULL
and	NULL
Tag23	NULL
,	NULL
revealed	NULL
a	NULL
very	NULL
low	NULL
level	NULL
of	NULL
transcripts	NULL
in	NULL
stimulated	NULL
spleen	NULL
and	NULL
thymus	NULL
cells	NULL
,	NULL
whereas	NULL
one	NULL
line	NULL
,	NULL
Tag8	NULL
,	NULL
was	NULL
a	NULL
strong	NULL
expressor	NULL
and	NULL
one	NULL
line	NULL
,	NULL
Tag9	NULL
,	NULL
was	NULL
intermediate	NULL
in	NULL
expression	NULL
.	NULL

The	NULL
tissue	NULL
specificity	NULL
of	NULL
NFAT-Tag	NULL
mRNA	NULL
expression	NULL
for	NULL
all	NULL
four	NULL
NFAT-Tag	NULL
lines	NULL
was	NULL
identical	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Further	NULL
studies	NULL
were	NULL
done	NULL
with	NULL
mice	NULL
belonging	NULL
to	NULL
lines	NULL
Tag8	NULL
and	NULL
Tag9	NULL
.	NULL

As	NULL
a	NULL
control	NULL
for	NULL
the	NULL
specific	NULL
effects	NULL
of	NULL
the	NULL
NFAT-1	NULL
binding	NULL
sites	NULL
we	NULL
analyzed	NULL
expression	NULL
of	NULL
the	NULL
transgene	NULL
in	NULL
mice	NULL
representing	NULL
lines	NULL
A52	NULL
,	NULL
A83	NULL
,	NULL
A94	NULL
,	NULL
and	NULL
A95	NULL
harboring	NULL
the	NULL
construct	NULL
without	NULL
NFAT-1	NULL
binding	NULL
sites	NULL
.	NULL

No	NULL
transcripts	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
stimulated	NULL
spleen	NULL
,	NULL
thymus	NULL
and	NULL
bone	NULL
marrow	NULL
cells	NULL
,	NULL
skin	NULL
,	NULL
and	NULL
other	NULL
tissues	NULL
from	NULL
mice	NULL
of	NULL
lines	NULL
A94	NULL
and	NULL
A95	NULL
.	NULL

Mice	NULL
from	NULL
the	NULL
other	NULL
two	NULL
lines	NULL
revealed	NULL
``	NULL
read	NULL
through	NULL
``	NULL
transcription	NULL
in	NULL
all	NULL
tissues	NULL
tested	NULL
but	NULL
no	NULL
properly	NULL
initiated	NULL
transcripts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Integration	NULL
of	NULL
the	NULL
transgene	NULL
in	NULL
these	NULL
two	NULL
lines	NULL
of	NULL
transgenic	NULL
mice	NULL
has	NULL
most	NULL
likely	NULL
occurred	NULL
at	NULL
a	NULL
locus	NULL
under	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
an	NULL
ubiquitously	NULL
active	NULL
promoter	NULL
.	NULL

From	NULL
this	NULL
data	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
observed	NULL
tissue-specific	NULL
expression	NULL
of	NULL
NFAT	NULL
-Tag	NULL
can	NULL
be	NULL
ascribed	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
NFAT-1	NULL
binding	NULL
sites	NULL
.	NULL

Kinetics	NULL
of	NULL
NFAT-Tag	NULL
mRNA	NULL
Expression-RNase	NULL
protection	NULL
analysis	NULL
was	NULL
used	NULL
to	NULL
study	NULL
the	NULL
time	NULL
course	NULL
of	NULL
induction	NULL
of	NULL
NFAT	NULL
mRNA	NULL
and	NULL
IL-2	NULL
mRNA	NULL
after	NULL
activation	NULL
of	NULL
spleen	NULL
cells	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

No	NULL
mRNA	NULL
was	NULL
detected	NULL
from	NULL
either	NULL
of	NULL
the	NULL
two	NULL
genes	NULL
prior	NULL
to	NULL
stimulation	NULL
.	NULL

Detectable	NULL
levels	NULL
of	NULL
mRNA	NULL
for	NULL
both	NULL
genes	NULL
were	NULL
present	NULL
after	NULL
1	NULL
h.	NULL
Comparison	NULL
of	NULL
the	NULL
later	NULL
kinetics	NULL
of	NULL
induction	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
with	NULL
the	NULL
transgene	NULL
in	NULL
both	NULL
thymus	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
spleen	NULL
cells	NULL
revealed	NULL
that	NULL
the	NULL
patterns	NULL
diverged	NULL
.	NULL

NFAT-Tag	NULL
mRNA	NULL
accumulates	NULL
until	NULL
36	NULL
h	NULL
while	NULL
IL-2	NULL
mRNA	NULL
accumulates	NULL
to	NULL
maximum	NULL
levels	NULL
at	NULL
6	NULL
h	NULL
post-stimulation	NULL
.	NULL

Cell	NULL
Type	NULL
Specificity	NULL
of	NULL
NFAT-Tag	NULL
mRNA	NULL
Expression-Based	NULL
on	NULL
in	NULL
vitro	NULL
studies	NULL
using	NULL
gel-shift	NULL
and	NULL
footprint	NULL
analyses	NULL
and	NULL
transient	NULL
expression	NULL
studies	NULL
we	NULL
anticipated	NULL
that	NULL
activated	NULL
T-cells	NULL
in	NULL
the	NULL
spleen	NULL
of	NULL
NFAT-Tag	NULL
mice	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
NFAT	NULL
transcription	NULL
(	NULL
Shaw	NULL
et	NULL
el	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
T-cell	NULL
specificity	NULL
of	NULL
NFAT	NULL
mRNA	NULL
expression	NULL
we	NULL
selectively	NULL
depleted	NULL
T-cells	NULL
from	NULL
splenocytes	NULL
prior	NULL
to	NULL
stimulation	NULL
by	NULL
complement	NULL
lysis	NULL
using	NULL
an	NULL
anti-Thy-1.2	NULL
monoclonal	NULL
anti-body	NULL
.	NULL

The	NULL
resulting	NULL
population	NULL
contained	NULL
about	NULL
90	NULL
%	NULL
B-cells	NULL
and	NULL
less	NULL
than	NULL
2	NULL
%	NULL
T-cells	NULL
.	NULL

Analysis	NULL
of	NULL
IL-2	NULL
mRNA	NULL
indicated	NULL
that	NULL
only	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
IL-2	NULL
mRNA	NULL
was	NULL
present	NULL
in	NULL
the	NULL
remaining	NULL
cells	NULL
after	NULL
activation	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
,	NULL
indicating	NULL
depletion	NULL
of	NULL
most	NULL
of	NULL
the	NULL
T-cells	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

In	NULL
the	NULL
T-cell-depleted	NULL
spleen	NULL
no	NULL
NFAT-Tag	NULL
mRNA	NULL
could	NULL
be	NULL
detected	NULL
1	NULL
and	NULL
2	NULL
h	NULL
after	NULL
stimulation	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
;	NULL
however	NULL
,	NULL
after	NULL
24	NULL
h	NULL
synthesis	NULL
of	NULL
approximately	NULL
similar	NULL
amounts	NULL
of	NULL
NFAT	NULL
-Tag	NULL
transcripts	NULL
in	NULL
total	NULL
spleen	NULL
and	NULL
T-cell-depleted	NULL
spleen	NULL
were	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

Thus	NULL
it	NULL
appears	NULL
that	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san§	NULL
4q	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
duy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
NFAT-1	NULL
Transcriptional	NULL
Activity	NULL
in	NULL
Transgenic	NULL
Mice	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

NFAT-Tag	NULL
mRNA	NULL
levels	NULL
in	NULL
tissues	NULL
of	NULL
transgenic	NULL
mice	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
tissues	NULL
of	NULL
a	NULL
6-week-old	NULL
mouse	NULL
of	NULL
line	NULL
Tag8	NULL
.	NULL

Spleen	NULL
,	NULL
thymus	NULL
,	NULL
and	NULL
bone	NULL
marrow	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ionomycin	NULL
(	NULL
0.6	NULL
aM	NULL
)	NULL
and	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

Ten	NULL
ug	NULL
of	NULL
each	NULL
RNA	NULL
sample	NULL
was	NULL
used	NULL
in	NULL
an	NULL
RNase	NULL
protection	NULL
assay	NULL
.	NULL

As	NULL
probe	NULL
we	NULL
used	NULL
the	NULL
176-nucleotide	NULL
P-labeled	NULL
antisense	NULL
NFAT-Tag	NULL
RNA	NULL
probe	NULL
.	NULL

Correctly	NULL
initiated	NULL
mRNA	NULL
would	NULL
yield	NULL
a	NULL
47-nucleotide	NULL
protected	NULL
fragment	NULL
.	NULL

The	NULL
position	NULL
of	NULL
this	NULL
fragment	NULL
(	NULL
Tag	NULL
)	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

g	NULL
time	NULL
(	NULL
hrs	NULL
)	NULL
50	NULL
1	NULL
3	NULL
6121824	NULL
36m	NULL
A	NULL
)	NULL
Tag	NULL
-m	NULL
123	NULL
45	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
B	NULL
)	NULL
'	NULL
--	NULL
sun	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
NFAT-Tag	NULL
and	NULL
IL-2	NULL
gene	NULL
expression	NULL
after	NULL
stimulation	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
.	NULL

Spleen	NULL
cells	NULL
(	NULL
5-10	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
and	NULL
harvested	NULL
at	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
after	NULL
stimulation	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
by	NULL
the	NULL
hot	NULL
phenol	NULL
method	NULL
(	NULL
Verweij	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
and	NULL
10	NULL
ug	NULL
was	NULL
used	NULL
for	NULL
detection	NULL
of	NULL
NFAT	NULL
-Tag	NULL
mRNA	NULL
(	NULL
A	NULL
)	NULL
and	NULL
IL-2	NULL
mRNA	NULL
(	NULL
B	NULL
)	NULL
by	NULL
RNase	NULL
protection	NULL
analysis	NULL
.	NULL

As	NULL
probes	NULL
we	NULL
used	NULL
the	NULL
176-nucleotide	NULL
``	NULL
*P	NULL
-labeled	NULL
antisense	NULL
NFAT	NULL
-Tag	NULL
RNA	NULL
fragment	NULL
and	NULL
a	NULL
420-nucleotide	NULL
*P	NULL
-labeled	NULL
antisense	NULL
IL-2	NULL
RNA	NULL
fragment	NULL
,	NULL
yielding	NULL
protected	NULL
fragments	NULL
from	NULL
hybridization	NULL
with	NULL
correctly	NULL
initiated	NULL
transcripts	NULL
with	NULL
a	NULL
length	NULL
of	NULL
47	NULL
nucleotides	NULL
(	NULL
Tag	NULL
)	NULL
and	NULL
400	NULL
nucleotides	NULL
(	NULL
IL-2	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
position	NULL
of	NULL
these	NULL
fragments	NULL
in	NULL
the	NULL
gel	NULL
are	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

at	NULL
the	NULL
1-	NULL
and	NULL
2-h	NULL
time	NULL
points	NULL
the	NULL
NFAT	NULL
mRNA	NULL
originates	NULL
from	NULL
T-cells	NULL
while	NULL
after	NULL
24	NULL
h	NULL
the	NULL
majority	NULL
of	NULL
NFAT-Tag	NULL
mRNA	NULL
synthesized	NULL
in	NULL
total	NULL
spleen	NULL
cell	NULL
cultures	NULL
originates	NULL
from	NULL
non-T-cells	NULL
.	NULL

To	NULL
further	NULL
explore	NULL
the	NULL
cell	NULL
type	NULL
specificity	NULL
of	NULL
NFAT-Tag	NULL
transcription	NULL
we	NULL
purified	NULL
B-	NULL
and	NULL
T-cells	NULL
from	NULL
a	NULL
splenocyte	NULL
suspension	NULL
.	NULL

First	NULL
we	NULL
enriched	NULL
for	NULL
either	NULL
B-	NULL
or	NULL
T-cells	NULL
using	NULL
lineage-specific	NULL
antibodies	NULL
plus	NULL
magnetic	NULL
beads	NULL
followed	NULL
by	NULL
cell	NULL
sorting	NULL
on	NULL
the	NULL
FACS	NULL
.	NULL

Populations	NULL
of	NULL
B-	NULL
and	NULL
T-cells	NULL
,	NULL
each	NULL
approximately	NULL
of	NULL
99.5	NULL
%	NULL
purity	NULL
,	NULL
were	NULL
obtained	NULL
and	NULL
tested	NULL
for	NULL
NFAT	NULL
-Tag	NULL
transcriptional	NULL
activity	NULL
.	NULL

As	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

44	NULL
in	NULL
both	NULL
cell	NULL
populations	NULL
transcription	NULL
was	NULL
induced	NULL
after	NULL
24	NULL
h	NULL
of	NULL
stimulation	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
.	NULL

Activation	NULL
Requirements	NULL
for	NULL
NFAT-Tag	NULL
mRNA	NULL
Expres-sion-Ionomycin	NULL
and	NULL
PMA	NULL
provide	NULL
two	NULL
signals	NULL
,	NULL
i.e	NULL
.	NULL

an	NULL
increase	NULL
in	NULL
intracellular	NULL
calcium	NULL
and	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
respectively	NULL
,	NULL
required	NULL
for	NULL
IL-2	NULL
gene	NULL
expression	NULL
and	NULL
T-cell	NULL
activation	NULL
.	NULL

These	NULL
stimuli	NULL
bypass	NULL
interaction	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
an	NULL
antigen	NULL
and	NULL
the	NULL
proper	NULL
histocompatibility	NULL
molecules	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
antigen-pre-senting	NULL
cells	NULL
(	NULL
Wiskocil	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Weiss	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
;	NULL
Truneh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Imboden	NULL
and	NULL
Stobo	NULL
,	NULL
1985	NULL
)	NULL
.	NULL

We	NULL
determined	NULL
whether	NULL
the	NULL
NFAT	NULL
-Tag	NULL
transgene	NULL
responded	NULL
to	NULL
physiological	NULL
stimuli	NULL
by	NULL
replacing	NULL
ionomycin	NULL
with	NULL
either	NULL
of	NULL
two	NULL
polyclonal	NULL
stimuli	NULL
that	NULL
could	NULL
mimic	NULL
physiological	NULL
triggering	NULL
by	NULL
binding	NULL
with	NULL
the	NULL
antigen	NULL
receptor	NULL
,	NULL
ie	NULL
.	NULL

ConA	NULL
and	NULL
anti-CD3	NULL
.	NULL

RNase	NULL
protection	NULL
was	NULL
used	NULL
to	NULL
quantitate	NULL
NFAT-Tag	NULL
and	NULL
IL-2	NULL
transcripts	NULL
in	NULL
splenocytes	NULL
from	NULL
transgenic	NULL
mice	NULL
stimulated	NULL
with	NULL
these	NULL
different	NULL
stimuli	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Stimulation	NULL
with	NULL
ionomycin	NULL
alone	NULL
induced	NULL
considerably	NULL
less	NULL
NFAT	NULL
mRNA	NULL
compared	NULL
with	NULL
ionomycin-	NULL
and	NULL
PMA-stimulated	NULL
cells	NULL
,	NULL
while	NULL
PMA	NULL
by	NULL
itself	NULL
did	NULL
not	NULL
induce	NULL
NFAT-Tag	NULL
transcription	NULL
within	NULL
our	NULL
detection	NULL
limits	NULL
which	NULL
are	NULL
less	NULL
than	NULL
one	NULL
transcript/cell	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
PMA	NULL
facilitates	NULL
the	NULL
induction	NULL
of	NULL
NFAT	NULL
Tag	NULL
mRNA	NULL
but	NULL
is	NULL
insufficient	NULL
alone	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
stimulation	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san§	NULL
4q	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
duy	NULL
wou	NULL
;	NULL
15792	NULL
§	NULL
x	NULL
A	NULL
)	NULL
-	NULL
time	NULL
(	NULL
hrs	NULL
)	NULL
24	NULL
§	NULL
10	NULL
met	NULL
1	NULL
2	NULL
34	NULL
5	NULL
678	NULL
910	NULL
111213	NULL
&	NULL
\'~	NULL
``	NULL
\	NULL
ff	NULL
«	NULL
wax	NULL
B	NULL
)	NULL
s	NULL
C	NULL
}	NULL
|=	NULL
dad	NULL
$	NULL
it	NULL
$	NULL
&	NULL
12.345	NULL
1	NULL
23456	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Cell	NULL
type	NULL
specificity	NULL
and	NULL
inducibility	NULL
of	NULL
NFAT-Tag	NULL
mRNA	NULL
expression	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

A	NULL
,	NULL
RNase	NULL
protection	NULL
analysis	NULL
was	NULL
used	NULL
to	NULL
determine	NULL
inducible	NULL
transcription	NULL
of	NULL
NFAT	NULL
-Tag	NULL
mRNA	NULL
in	NULL
splenocyte	NULL
subsets	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
iono	NULL
)	NULL
(	NULL
0.6	NULL
aM	NULL
)	NULL
and	NULL
harvested	NULL
for	NULL
RNA	NULL
analysis	NULL
at	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
.	NULL

Ten	NULL
ug	NULL
of	NULL
each	NULL
sample	NULL
(	NULL
3	NULL
ug	NULL
for	NULL
the	NULL
purified	NULL
B-	NULL
and	NULL
T-cells	NULL
)	NULL
was	NULL
used	NULL
for	NULL
NFAT-Tag	NULL
mRNA	NULL
analysis	NULL
.	NULL

Results	NULL
obtained	NULL
from	NULL
mice	NULL
of	NULL
line	NULL
Tag8	NULL
and	NULL
Tag9	NULL
are	NULL
shown	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
protected	NULL
fragments	NULL
using	NULL
RNA	NULL
from	NULL
spleen	NULL
cells	NULL
of	NULL
a	NULL
Tag9	NULL
mouse	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
T-cell-depleted	NULL
spleen	NULL
cells	NULL
(	NULL
T7	NULL
)	NULL
of	NULL
a	NULL
Tag9	NULL
mouse	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
T-cell-depleted	NULL
spleen	NULL
cells	NULL
of	NULL
a	NULL
Tag9	NULL
mouse	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
T-cell-depleted	NULL
spleen	NULL
cells	NULL
of	NULL
a	NULL
Tag8	NULL
mouse	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
T-cell-depleted	NULL
spleen	NULL
cells	NULL
of	NULL
a	NULL
Tag8	NULL
mouse	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
;	NULL
lame	NULL
6	NULL
,	NULL
T-cell-depleted	NULL
spleen	NULL
cells	NULL
of	NULL
a	NULL
Tag	NULL
mouse	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
total	NULL
spleen	NULL
of	NULL
a	NULL
Tags	NULL
mouse	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
;	NULL
lane	NULL
8	NULL
,	NULL
size	NULL
markers	NULL
(	NULL
M	NULL
)	NULL
;	NULL
lane	NULL
9	NULL
,	NULL
total	NULL
spleen	NULL
cells	NULL
of	NULL
a	NULL
Tag8	NULL
mouse	NULL
stimulated	NULL
for	NULL
1	NULL
h	NULL
;	NULL
lane	NULL
10	NULL
,	NULL
T-cell-depleted	NULL
spleen	NULL
cells	NULL
of	NULL
a	NULL
Tag8	NULL
mouse	NULL
stimulated	NULL
for	NULL
1	NULL
h	NULL
;	NULL
lane	NULL
11	NULL
,	NULL
total	NULL
spleen	NULL
cells	NULL
of	NULL
a	NULL
Tag8	NULL
mouse	NULL
nonstimulated	NULL
(	NULL
ns	NULL
)	NULL
for	NULL
24	NULL
h	NULL
;	NULL
lane	NULL
12	NULL
,	NULL
purified	NULL
B-cells	NULL
(	NULL
B	NULL
)	NULL
of	NULL
a	NULL
Tag8	NULL
mouse	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
;	NULL
and	NULL
lane	NULL
13	NULL
,	NULL
purified	NULL
T-cells	NULL
(	NULL
T	NULL
)	NULL
of	NULL
a	NULL
Tag	NULL
mouse	NULL
stimulated	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
position	NULL
of	NULL
the	NULL
protected	NULL
fragment	NULL
(	NULL
Tag	NULL
)	NULL
is	NULL
indicated	NULL
.	NULL

B	NULL
,	NULL
splenocytes	NULL
from	NULL
a	NULL
Tag	NULL
mouse	NULL
were	NULL
cultured	NULL
for	NULL
6	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
indicated	NULL
stimuli	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
.	NULL

Ten	NULL
ug	NULL
was	NULL
assayed	NULL
for	NULL
correctly	NULL
initiated	NULL
NFAT	NULL
mRNA	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
protected	NULL
fragment	NULL
(	NULL
Tag	NULL
)	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

C	NULL
,	NULL
responsiveness	NULL
of	NULL
splenocytes	NULL
and	NULL
T-cell-depleted	NULL
cells	NULL
to	NULL
the	NULL
indicated	NULL
stimuli	NULL
was	NULL
determined	NULL
by	NULL
assaying	NULL
for	NULL
IL-2	NULL
mRNA	NULL
production	NULL
after	NULL
stimulation	NULL
for	NULL
6	NULL
h	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
and	NULL
24	NULL
h	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
arrow	NULL
shows	NULL
the	NULL
position	NULL
of	NULL
the	NULL
protected	NULL
fragment	NULL
(	NULL
IL-2	NULL
)	NULL
.	NULL

of	NULL
splenocytes	NULL
with	NULL
ConA	NULL
or	NULL
anti-CD3	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
for	NULL
6	NULL
h	NULL
resulted	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
NFAT-Tag	NULL
mRNA	NULL
tran-scription	NULL
,	NULL
although	NULL
the	NULL
levels	NULL
were	NULL
low	NULL
compared	NULL
to	NULL
the	NULL
signal	NULL
from	NULL
ionomycin-	NULL
and	NULL
PMA-stimulated	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
ConA	NULL
and	NULL
anti-CD3	NULL
also	NULL
stimulated	NULL
lower	NULL
levels	NULL
of	NULL
IL-2	NULL
mRNA	NULL
than	NULL
ionomycin	NULL
and	NULL
PMA	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
activation	NULL
signals	NULL
necessary	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
IL-2	NULL
gene	NULL
are	NULL
qualitatively	NULL
and	NULL
quantitatively	NULL
similar	NULL
to	NULL
those	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
NFAT	NULL
-Tag	NULL
transgene	NULL
.	NULL

Expression	NULL
of	NULL
SV40	NULL
T-antigen	NULL
Gene	NULL
Product-RNase	NULL
protection	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
NFAT-Tag	NULL
mRNA	NULL
is	NULL
expressed	NULL
in	NULL
lymphocytes	NULL
after	NULL
induction	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
and	NULL
in	NULL
skin	NULL
without	NULL
induction	NULL
.	NULL

To	NULL
ascertain	NULL
that	NULL
this	NULL
NFAT-1	NULL
Transcriptional	NULL
Activity	NULL
in	NULL
Transgenic	NULL
Mice	NULL
expression	NULL
correlates	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
SV40	NULL
T-antigen	NULL
protein	NULL
we	NULL
stained	NULL
histological	NULL
preparations	NULL
of	NULL
tissue	NULL
from	NULL
NFAT-Tag	NULL
mice	NULL
for	NULL
T-antigen	NULL
.	NULL

As	NULL
antibody	NULL
we	NULL
used	NULL
the	NULL
monoclonal	NULL
antibody	NULL
PB101	NULL
,	NULL
directed	NULL
against	NULL
the	NULL
COOH-terminal	NULL
part	NULL
of	NULL
T-antigen	NULL
(	NULL
Gurney	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1980	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
T-antigen	NULL
could	NULL
be	NULL
detected	NULL
by	NULL
direct	NULL
staining	NULL
of	NULL
a	NULL
fluorescein	NULL
isothiocyanate-conjugated	NULL
monoclonal	NULL
antibodies	NULL
in	NULL
nuclei	NULL
of	NULL
stimulated	NULL
spleen	NULL
and	NULL
thymus	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

About	NULL
15	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
stained	NULL
positively	NULL
for	NULL
T-antigen	NULL
.	NULL

Immunocy-tochemical	NULL
analysis	NULL
of	NULL
skin	NULL
sections	NULL
showed	NULL
a	NULL
small	NULL
number	NULL
of	NULL
T-antigen-positive	NULL
cells	NULL
in	NULL
the	NULL
dermis	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Correlation	NULL
of	NULL
NFAT-Tag	NULL
Transcription	NULL
with	NULL
NFAT-1	NULL
Binding	NULL
Activity-To	NULL
determine	NULL
whether	NULL
NFAT-Tag	NULL
transcription	NULL
correlates	NULL
with	NULL
NFAT-1	NULL
binding	NULL
activity	NULL
we	NULL
prepared	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
stimulated	NULL
under	NULL
conditions	NULL
known	NULL
to	NULL
regulate	NULL
NFAT-1	NULL
(	NULL
Fig	NULL
.	NULL

64	NULL
)	NULL
.	NULL

No	NULL
NFAT-1	NULL
binding	NULL
activity	NULL
assayed	NULL
by	NULL
gel	NULL
retardation	NULL
was	NULL
detected	NULL
in	NULL
liver	NULL
cells	NULL
and	NULL
brain	NULL
cells	NULL
.	NULL

A	NULL
faint	NULL
band	NULL
was	NULL
observed	NULL
using	NULL
extracts	NULL
of	NULL
unstimulated	NULL
spleen	NULL
.	NULL

Significantly	NULL
more	NULL
binding	NULL
activity	NULL
was	NULL
present	NULL
in	NULL
extracts	NULL
from	NULL
spleen	NULL
and	NULL
T-cell	NULL
depleted	NULL
spleen	NULL
after	NULL
stimulation	NULL
.	NULL

A	NULL
100-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
NFAT-1	NULL
oligonucleotide	NULL
competed	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
NFAT-1	NULL
com-plex	NULL
.	NULL

No	NULL
inhibition	NULL
of	NULL
complex	NULL
formation	NULL
was	NULL
observed	NULL
when	NULL
a	NULL
similar	NULL
excess	NULL
of	NULL
the	NULL
HNF-1	NULL
binding	NULL
sequence	NULL
beta-28	NULL
(	NULL
Courtois	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
was	NULL
used	NULL
as	NULL
competitor	NULL
,	NULL
indicating	NULL
that	NULL
binding	NULL
was	NULL
sequence	NULL
specific	NULL
.	NULL

Splenic	NULL
B-cells	NULL
consist	NULL
of	NULL
a	NULL
heterogenous	NULL
population	NULL
of	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
done	NULL
some	NULL
preliminary	NULL
studies	NULL
on	NULL
NFAT-1	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
murine	NULL
B-cell	NULL
leukemia	NULL
70	NULL
%	NULL
/3	NULL
(	NULL
Paige	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1978	NULL
)	NULL
and	NULL
the	NULL
murine	NULL
ly1*	NULL
B-cell	NULL
line	NULL
5B2.1	NULL
(	NULL
Lainer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1981	NULL
)	NULL
.	NULL

In	NULL
one	NULL
of	NULL
these	NULL
cell	NULL
lines	NULL
,	NULL
5B2.1	NULL
,	NULL
we	NULL
could	NULL
detect	NULL
inducible	NULL
NFAT-1	NULL
binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
cells	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

So	NULL
far	NULL
3	NULL
mice	NULL
(	NULL
1	NULL
Tag8	NULL
mouse	NULL
and	NULL
2	NULL
Tag	NULL
)	NULL
mice	NULL
)	NULL
from	NULL
a	NULL
group	NULL
of	NULL
17	NULL
mice	NULL
(	NULL
7	NULL
Tag8	NULL
and	NULL
10	NULL
Tag9	NULL
)	NULL
which	NULL
were	NULL
observed	NULL
for	NULL
a	NULL
period	NULL
of	NULL
1	NULL
year	NULL
have	NULL
developed	NULL
dermal	NULL
sjuuag	NULL
FiG	NULL
.	NULL

5	NULL
.	NULL

Immunofluorescence	NULL
staining	NULL
of	NULL
stimulated	NULL
spleen	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
and	NULL
a	NULL
skin	NULL
section	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Fluorescein	NULL
isothiocyanate-conjugated	NULL
PB101	NULL
(	NULL
anti-T-antigen	NULL
)	NULL
was	NULL
used	NULL
at	NULL
a	NULL
dilution	NULL
of	NULL
1/1000	NULL
to	NULL
detect	NULL
expression	NULL
of	NULL
T-antigen	NULL
in	NULL
a	NULL
cytospin	NULL
preparation	NULL
of	NULL
Tags	NULL
spleen	NULL
cells	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
(	NULL
A	NULL
)	NULL
and	NULL
a	NULL
methanol-fixed	NULL
section	NULL
of	NULL
Tag9	NULL
skin	NULL
from	NULL
the	NULL
tail	NULL
(	NULL
B	NULL
)	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san§	NULL
4q	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
duy	NULL
wou	NULL
;	NULL
NFAT-1	NULL
Transcriptional	NULL
Activity	NULL
in	NULL
Transgenic	NULL
Mice	NULL
i	NULL
or	NULL
:	NULL
5	NULL
5	NULL
5	NULL
%	NULL
Tumor	NULL
ens	NULL
__-T+	NULL
+	NULL
Elbarr	NULL
oc	NULL
53:55	NULL
ﬁllienlligg	NULL
A	NULL
)	NULL
®	NULL
.	NULL

NFAT	NULL
=i	NULL
»	NULL
ip	NULL
«	NULL
i	NULL
>	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
1213	NULL
14151617	NULL
18	NULL
NFAT	NULL
mut	NULL
x11	NULL
e=	NULL
]	NULL
x	NULL
tp	NULL
Ns	NULL
s	NULL
X	NULL
2	NULL
2	NULL
x	NULL
2	NULL
5	NULL
B	NULL
)	NULL
5	NULL
NFAT	NULL
tp	NULL
=i	NULL
»	NULL
10	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
T	NULL
8	NULL
9	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Binding	NULL
of	NULL
inducible	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
NFAT	NULL
1	NULL
motif	NULL
.	NULL

A	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
tissues	NULL
from	NULL
a	NULL
C57B16	NULL
mouse	NULL
.	NULL

Equivalent	NULL
amounts	NULL
(	NULL
3	NULL
ug	NULL
)	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
brain	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
liver	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
PMA	NULL
+	NULL
ionomycin-stimulated	NULL
(	NULL
24	NULL
h	NULL
)	NULL
spleen	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
12	NULL
)	NULL
,	NULL
PMA	NULL
+	NULL
ionomycin-stimulated	NULL
(	NULL
24	NULL
h	NULL
)	NULL
T-cell-depleted	NULL
spleen	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
15	NULL
)	NULL
,	NULL
unstimulated	NULL
spleen	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
ionomycin	NULL
+	NULL
PMA-stimulated	NULL
(	NULL
4	NULL
h	NULL
)	NULL
Jurkat	NULL
cells	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
18	NULL
)	NULL
,	NULL
and	NULL
dermal	NULL
tumor	NULL
cells	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
double-stranded	NULL
**P-labeled	NULL
NFAT-1	NULL
binding	NULL
site	NULL
,	NULL
and	NULL
free	NULL
DNA	NULL
(	NULL
fp	NULL
)	NULL
and	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
4	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
dermal	NULL
tumor	NULL
cells	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
,	NULL
stimulated	NULL
spleen	NULL
(	NULL
lanes	NULL
13	NULL
and	NULL
14	NULL
)	NULL
and	NULL
T-cell-depleted	NULL
spleen	NULL
(	NULL
lanes	NULL
16	NULL
and	NULL
17	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
``	NULL
*P	NULL
-labeled	NULL
NFAT	NULL
-1	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
NFAT-1	NULL
binding	NULL
site	NULL
(	NULL
lanes	NULL
9	NULL
,	NULL
13	NULL
,	NULL
and	NULL
16	NULL
)	NULL
or	NULL
8-28	NULL
(	NULL
hepatocyte	NULL
nuclear	NULL
factor	NULL
binding	NULL
site	NULL
)	NULL
(	NULL
lanes	NULL
10	NULL
,	NULL
14	NULL
,	NULL
and	NULL
17	NULL
)	NULL
.	NULL

Mobility	NULL
of	NULL
the	NULL
P-labeled	NULL
oligonucleotide	NULL
incubated	NULL
without	NULL
extract	NULL
is	NULL
also	NULL
shown	NULL
(	NULL
lanes	NULL
I	NULL
and	NULL
11	NULL
)	NULL
.	NULL

B	NULL
,	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
the	NULL
Ly1*	NULL
B-cell	NULL
line	NULL
5B2.1	NULL
before	NULL
(	NULL
NS	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
after	NULL
stimulation	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
(	NULL
S	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
P-labeled	NULL
NFAT	NULL
binding	NULL
site	NULL
.	NULL

A	NULL
1-	NULL
,	NULL
10-	NULL
,	NULL
and	NULL
100-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
NFAT-1	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
and	NULL
mutant	NULL
NFAT-1	NULL
(	NULL
mut	NULL
)	NULL
(	NULL
lanes	NULL
7-9	NULL
)	NULL
oligonucleotides	NULL
were	NULL
added	NULL
to	NULL
the	NULL
extracts	NULL
of	NULL
stimulated	NULL
cells	NULL
as	NULL
competitor	NULL
.	NULL

The	NULL
mutant	NULL
oligonucleotide	NULL
contains	NULL
four	NULL
G	NULL
to	NULL
T	NULL
substitutions	NULL
in	NULL
the	NULL
contact	NULL
G	NULL
residues	NULL
and	NULL
has	NULL
the	NULL
sequence	NULL
5'-AAGAAAGGAGaAAAAAaTtTTTaATACAG-3	NULL
'	NULL
.	NULL

The	NULL
nucleotides	NULL
in	NULL
small	NULL
letters	NULL
are	NULL
the	NULL
mutated	NULL
guanosines	NULL
where	NULL
methylation	NULL
interferes	NULL
with	NULL
NFAT-1	NULL
binding	NULL
(	NULL
J.	NULL
P.	NULL
Shaw	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

tumors	NULL
.	NULL

Cells	NULL
from	NULL
these	NULL
tumors	NULL
were	NULL
positive	NULL
for	NULL
NFAT	NULL
-Tag	NULL
mRNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
consider	NULL
the	NULL
dermal	NULL
tumor	NULL
cells	NULL
representative	NULL
for	NULL
the	NULL
dermal	NULL
cells	NULL
expressing	NULL
the	NULL
transgene	NULL
constitutively	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
also	NULL
in	NULL
these	NULL
cells	NULL
the	NULL
appearance	NULL
of	NULL
NFAT	NULL
-Tag	NULL
mRNA	NULL
correlates	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
NFAT-1	NULL
binding	NULL
activity	NULL
we	NULL
assayed	NULL
tumor	NULL
cells	NULL
from	NULL
a	NULL
Tag9	NULL
mouse	NULL
for	NULL
NFAT-1	NULL
binding	NULL
activity	NULL
.	NULL

Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
cells	NULL
of	NULL
this	NULL
tumor	NULL
also	NULL
contained	NULL
NFAT	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

64	NULL
)	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
tumor	NULL
cells	NULL
15793	NULL
will	NULL
be	NULL
carried	NULL
out	NULL
and	NULL
be	NULL
published	NULL
elsewhere	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
observed	NULL
transcriptional	NULL
activity	NULL
of	NULL
NFAT-Tag	NULL
appears	NULL
to	NULL
correlate	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
NFAT-1	NULL
or	NULL
an	NULL
NFAT-1	NULL
like	NULL
binding	NULL
activity	NULL
.	NULL

Cyclosporin	NULL
A	NULL
Inhibits	NULL
NFAT-Tag	NULL
Transcription-Cyclo-sporin	NULL
A	NULL
is	NULL
known	NULL
to	NULL
inhibit	NULL
the	NULL
early	NULL
events	NULL
in	NULL
T-lymphocyte	NULL
activation	NULL
(	NULL
Kronke	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
;	NULL
Elliott	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
found	NULL
that	NULL
cyclosporin	NULL
A	NULL
specifically	NULL
inhibits	NULL
the	NULL
appearance	NULL
of	NULL
NFAT	NULL
binding	NULL
activity	NULL
(	NULL
Emmel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
cyclosporin	NULL
A	NULL
abolishes	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
NFAT-1	NULL
binding	NULL
site	NULL
to	NULL
activate	NULL
a	NULL
heterologous	NULL
promoter	NULL
in	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
.	NULL

Cyclosporin	NULL
A	NULL
at	NULL
100	NULL
ng/ml	NULL
totally	NULL
blocked	NULL
the	NULL
ability	NULL
of	NULL
ionomycin	NULL
and	NULL
PMA	NULL
for	NULL
2	NULL
,	NULL
6	NULL
,	NULL
and	NULL
24	NULL
h	NULL
to	NULL
activate	NULL
NFAT	NULL
transcription	NULL
in	NULL
splenocytes	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

This	NULL
result	NULL
demonstrates	NULL
the	NULL
physiological	NULL
significance	NULL
of	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
cyclosporin	NULL
A	NULL
on	NULL
NFAT-1	NULL
activity	NULL
and	NULL
further	NULL
substantiates	NULL
our	NULL
conclusion	NULL
that	NULL
NFAT-Tag	NULL
transcription	NULL
is	NULL
dependent	NULL
on	NULL
NFAT	NULL
-1	NULL
activity	NULL
.	NULL

DISCUSSION	NULL
We	NULL
used	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
30-bp	NULL
NFAT-1	NULL
binding	NULL
motif	NULL
to	NULL
direct	NULL
expression	NULL
of	NULL
T-antigen	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

We	NULL
have	NULL
provided	NULL
evidence	NULL
that	NULL
in	NULL
this	NULL
setting	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
transgene	NULL
is	NULL
indicative	NULL
for	NULL
NFAT-1	NULL
transcriptional	NULL
activity	NULL
.	NULL

First	NULL
,	NULL
the	NULL
regulatory	NULL
unit	NULL
used	NULL
was	NULL
shown	NULL
to	NULL
respond	NULL
to	NULL
signals	NULL
originating	NULL
at	NULL
the	NULL
T-cell	NULL
receptor	NULL
,	NULL
a	NULL
result	NULL
which	NULL
is	NULL
in	NULL
accord	NULL
with	NULL
the	NULL
previously	NULL
described	NULL
characteristics	NULL
for	NULL
NFAT-1	NULL
activation	NULL
(	NULL
Shaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
synthesis	NULL
of	NULL
properly	NULL
initiated	NULL
NFAT	NULL
mRNA	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
NFAT-1	NULL
binding	NULL
sites	NULL
.	NULL

Third	NULL
,	NULL
the	NULL
tissue-specific	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
transgene	NULL
was	NULL
shown	NULL
to	NULL
correlate	NULL
with	NULL
NFAT-1	NULL
binding	NULL
activity	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
transgene	NULL
could	NULL
be	NULL
blocked	NULL
by	NULL
cyclosporin	NULL
A	NULL
(	NULL
in	NULL
vitro	NULL
studies	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
NFAT-1	NULL
binding	NULL
activity	NULL
and	NULL
transcriptional	NULL
activity	NULL
could	NULL
specifically	NULL
be	NULL
blocked	NULL
with	NULL
cyclosporin	NULL
A	NULL
(	NULL
Emmel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
)	NULL
.	NULL

This	NULL
result	NULL
represents	NULL
the	NULL
first	NULL
demonstration	NULL
that	NULL
oligomerized	NULL
binding	NULL
sites	NULL
for	NULL
an	NULL
individual	NULL
nuclear	NULL
factor	NULL
can	NULL
give	NULL
appropriate	NULL
transcriptional	NULL
regulation	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Hence	NULL
,	NULL
this	NULL
system	NULL
allows	NULL
detection	NULL
of	NULL
NFAT	NULL
-1	NULL
activity	NULL
in	NULL
individual	NULL
cells	NULL
in	NULL
a	NULL
physiological	NULL
background	NULL
and	NULL
circumvents	NULL
the	NULL
use	NULL
of	NULL
cell	NULL
lines	NULL
which	NULL
might	NULL
have	NULL
lost	NULL
normal	NULL
regulatory	NULL
control	NULL
and	NULL
thus	NULL
are	NULL
not	NULL
representative	NULL
of	NULL
normal	NULL
cell	NULL
physiology	NULL
.	NULL

The	NULL
similarity	NULL
in	NULL
NFAT-Tag	NULL
mRNA	NULL
expression	NULL
patterns	NULL
among	NULL
the	NULL
four	NULL
NFAT	NULL
lines	NULL
excludes	NULL
any	NULL
significant	NULL
effect	NULL
on	NULL
the	NULL
tissue	NULL
specificity	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
transgene	NULL
due	NULL
to	NULL
the	NULL
site	NULL
of	NULL
integration	NULL
in	NULL
the	NULL
genome	NULL
of	NULL
these	NULL
mice	NULL
.	NULL

However	NULL
,	NULL
the	NULL
variability	NULL
in	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
between	NULL
the	NULL
different	NULL
lines	NULL
24	NULL
_	NULL
time	NULL
(	NULL
hrs	NULL
)	NULL
-	NULL
+	NULL
CsA	NULL
tRNA	NULL
is	NULL
a	NULL
``	NULL
ul	NULL
1	NULL
23	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Inhibition	NULL
of	NULL
NFAT-Tag	NULL
transcription	NULL
by	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
.	NULL

Splenocytes	NULL
from	NULL
a	NULL
Tag8	NULL
mouse	NULL
were	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
for	NULL
2	NULL
,	NULL
6	NULL
,	NULL
and	NULL
24	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
cyclosporin	NULL
A	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
and	NULL
10	NULL
ug	NULL
of	NULL
each	NULL
sample	NULL
was	NULL
assayed	NULL
for	NULL
correctly	NULL
initiated	NULL
NFAT	NULL
-Tag	NULL
transcripts	NULL
by	NULL
RNase	NULL
protection	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
tRNA	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
+	NULL
cyclosporin	NULL
A	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
2	NULL
h	NULL
-	NULL
cyclosporin	NULL
A	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
6	NULL
h	NULL
-	NULL
cyclosporin	NULL
A	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
6	NULL
h	NULL
+	NULL
cyclosporin	NULL
A	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
24	NULL
h	NULL
-	NULL
cyclosporin	NULL
A	NULL
;	NULL
and	NULL
lane	NULL
8	NULL
,	NULL
24	NULL
h	NULL
+	NULL
cyclosporin	NULL
A	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
protected	NULL
fragment	NULL
(	NULL
Tag	NULL
)	NULL
indicative	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
properly	NULL
initiated	NULL
transcripts	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san§	NULL
4q	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
duy	NULL
wou	NULL
;	NULL
15794	NULL
could	NULL
be	NULL
attributed	NULL
to	NULL
influences	NULL
from	NULL
surrounding	NULL
sequences	NULL
.	NULL

Costimulation	NULL
of	NULL
ionomycin	NULL
with	NULL
PMA	NULL
leads	NULL
to	NULL
a	NULL
dramatic	NULL
increase	NULL
in	NULL
NFAT	NULL
transcription	NULL
compared	NULL
to	NULL
stimulation	NULL
with	NULL
ionomycin	NULL
alone	NULL
.	NULL

These	NULL
results	NULL
contrast	NULL
with	NULL
transient	NULL
expression	NULL
studies	NULL
in	NULL
Jurkat	NULL
cells	NULL
in	NULL
which	NULL
addition	NULL
of	NULL
PMA	NULL
did	NULL
not	NULL
contribute	NULL
much	NULL
to	NULL
NFAT-1	NULL
directed	NULL
transcription	NULL
(	NULL
Durand	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Since	NULL
in	NULL
the	NULL
transgenic	NULL
system	NULL
the	NULL
setting	NULL
of	NULL
the	NULL
transgene	NULL
is	NULL
in	NULL
a	NULL
physiological	NULL
background	NULL
we	NULL
favor	NULL
the	NULL
model	NULL
that	NULL
NFAT-1	NULL
requires	NULL
both	NULL
release	NULL
of	NULL
intracellular	NULL
calcium	NULL
and	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
to	NULL
exhibit	NULL
full	NULL
transcriptional	NULL
activity	NULL
.	NULL

In	NULL
our	NULL
studies	NULL
the	NULL
NFAT	NULL
-T	NULL
ag	NULL
transgene	NULL
was	NULL
expressed	NULL
more	NULL
broadly	NULL
than	NULL
the	NULL
endogenous	NULL
IL-2	NULL
gene	NULL
indicating	NULL
that	NULL
other	NULL
elements	NULL
than	NULL
the	NULL
NFAT-1	NULL
binding	NULL
motif	NULL
are	NULL
required	NULL
for	NULL
the	NULL
cell	NULL
type-specific	NULL
expression	NULL
of	NULL
IL-2	NULL
.	NULL

T-cells	NULL
as	NULL
well	NULL
as	NULL
B-cells	NULL
can	NULL
be	NULL
activated	NULL
to	NULL
exhibit	NULL
NFAT	NULL
activity	NULL
.	NULL

A	NULL
small	NULL
subpop-ulation	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
skin	NULL
show	NULL
this	NULL
activity	NULL
without	NULL
stimulation	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
NFAT-1	NULL
activation	NULL
pathway	NULL
is	NULL
not	NULL
restricted	NULL
to	NULL
one	NULL
cell	NULL
type	NULL
.	NULL

Since	NULL
both	NULL
calcium	NULL
and	NULL
protein	NULL
kinase	NULL
C	NULL
mediate	NULL
NFAT-1	NULL
activation	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
NFAT	NULL
1	NULL
is	NULL
a	NULL
general	NULL
effector	NULL
at	NULL
the	NULL
end	NULL
of	NULL
signal	NULL
transduction	NULL
pathways	NULL
originating	NULL
at	NULL
different	NULL
cell	NULL
surface	NULL
receptors	NULL
that	NULL
use	NULL
calcium	NULL
and	NULL
protein	NULL
kinase	NULL
C	NULL
as	NULL
intermediates	NULL
.	NULL

For	NULL
T-lymphocytes	NULL
NFAT-1	NULL
activity	NULL
is	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
signals	NULL
initiated	NULL
at	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
.	NULL

We	NULL
have	NULL
not	NULL
been	NULL
able	NULL
to	NULL
identify	NULL
yet	NULL
the	NULL
physiological	NULL
stimulus	NULL
for	NULL
the	NULL
splenic	NULL
B-cells	NULL
.	NULL

Stimulation	NULL
of	NULL
splenocytes	NULL
with	NULL
lipopolysaccharide	NULL
did	NULL
not	NULL
induce	NULL
NFAT	NULL
-Tag	NULL
mRNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
difference	NULL
in	NULL
kinetics	NULL
of	NULL
appearance	NULL
of	NULL
NFAT	NULL
-Tag	NULL
mRNA	NULL
in	NULL
total	NULL
spleen	NULL
cells	NULL
versus	NULL
T-cell	NULL
depleted	NULL
spleen	NULL
.	NULL

Early	NULL
expression	NULL
of	NULL
NFAT	NULL
mRNA	NULL
,	NULL
i.e	NULL
.	NULL

2	NULL
h	NULL
after	NULL
induction	NULL
,	NULL
seems	NULL
to	NULL
originate	NULL
exclusively	NULL
from	NULL
T-cells	NULL
while	NULL
after	NULL
24	NULL
h	NULL
the	NULL
majority	NULL
of	NULL
NFAT	NULL
mRNA	NULL
comes	NULL
from	NULL
non-T-cells	NULL
.	NULL

This	NULL
observation	NULL
makes	NULL
it	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
temporal	NULL
differences	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
NFAT-1	NULL
activity	NULL
determine	NULL
T-cell-specific	NULL
expression	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

Previous	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
AP1	NULL
,	NULL
NFIL-2A	NULL
,	NULL
NF-kB	NULL
,	NULL
and	NULL
NFAT-1	NULL
sites	NULL
must	NULL
be	NULL
present	NULL
for	NULL
full	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
enhancer	NULL
(	NULL
Durand	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Serfling	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Hoyos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Simultaneous	NULL
occupancy	NULL
of	NULL
all	NULL
these	NULL
sites	NULL
is	NULL
probably	NULL
essential	NULL
for	NULL
the	NULL
cell	NULL
type-specific	NULL
initiation	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
IL-2	NULL
mRNA	NULL
was	NULL
first	NULL
detectable	NULL
45	NULL
min	NULL
after	NULL
stimulation	NULL
(	NULL
Shaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

The	NULL
cellular	NULL
proto-oncogene	NULL
product	NULL
c-fos	NULL
is	NULL
induced	NULL
within	NULL
15	NULL
min	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
c-jun	NULL
,	NULL
and	NULL
this	NULL
complex	NULL
,	NULL
AP-1	NULL
,	NULL
binds	NULL
with	NULL
high	NULL
affinity	NULL
to	NULL
the	NULL
TPA	NULL
response	NULL
element	NULL
,	NULL
leading	NULL
to	NULL
AP-1-dependent	NULL
transcription	NULL
(	NULL
Reed	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Rauscher	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Franza	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
NF-kB	NULL
and	NULL
NFIL-2A	NULL
transcriptional	NULL
activity	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
induced	NULL
within	NULL
30	NULL
min	NULL
(	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Chiu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
1986	NULL
;	NULL
Ullman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

According	NULL
to	NULL
this	NULL
model	NULL
,	NULL
early	NULL
activated	NULL
NFAT-1	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
IL-2	NULL
gene	NULL
activation	NULL
and	NULL
the	NULL
temporal	NULL
regulation	NULL
of	NULL
NFAT-1	NULL
activity	NULL
might	NULL
account	NULL
for	NULL
the	NULL
observed	NULL
T-cell	NULL
specificity	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
NFAT	NULL
-Tag	NULL
transgene	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
skin	NULL
.	NULL

The	NULL
expressing	NULL
cells	NULL
are	NULL
localized	NULL
in	NULL
the	NULL
dermis	NULL
.	NULL

Some	NULL
mice	NULL
have	NULL
developed	NULL
dermal	NULL
tumors	NULL
which	NULL
express	NULL
the	NULL
transgene	NULL
.	NULL

By	NULL
gel	NULL
retardation	NULL
analysis	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
tumor	NULL
cells	NULL
contain	NULL
NFAT-1	NULL
binding	NULL
activity	NULL
,	NULL
indicative	NULL
that	NULL
transcription	NULL
in	NULL
these	NULL
cells	NULL
is	NULL
directed	NULL
by	NULL
NFAT-1	NULL
,	NULL
An	NULL
analogy	NULL
of	NULL
the	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
NFAT	NULL
-Tag	NULL
with	NULL
that	NULL
of	NULL
the	NULL
HIV-LTR/tat	NULL
transgene	NULL
(	NULL
Vogel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
can	NULL
be	NULL
drawn	NULL
.	NULL

Apart	NULL
from	NULL
the	NULL
dermis	NULL
constitutive	NULL
expression	NULL
of	NULL
both	NULL
NFAT	NULL
-Tag	NULL
and	NULL
HIV-LTR/tat	NULL
was	NULL
absent	NULL
in	NULL
any	NULL
tissue	NULL
tested	NULL
.	NULL

HIV-LTR	NULL
contains	NULL
sequence	NULL
motifs	NULL
within	NULL
functional	NULL
regions	NULL
NFAT-1	NULL
Transcriptional	NULL
Activity	NULL
in	NULL
Transgenic	NULL
Mice	NULL
which	NULL
have	NULL
the	NULL
potential	NULL
to	NULL
bind	NULL
nuclear	NULL
proteins	NULL
.	NULL

Besides	NULL
two	NULL
binding	NULL
sites	NULL
for	NULL
NF-kB	NULL
two	NULL
motifs	NULL
which	NULL
bind	NULL
NFAT-1	NULL
or	NULL
NFAT-1-like	NULL
protein	NULL
are	NULL
described	NULL
(	NULL
Shaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

NFAT-1	NULL
is	NULL
generally	NULL
believed	NULL
to	NULL
contribute	NULL
to	NULL
HIV-LTR	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
physiological	NULL
T-cell	NULL
activation	NULL
signals	NULL
and	NULL
might	NULL
account	NULL
for	NULL
the	NULL
partial	NULL
inhibition	NULL
of	NULL
HIV-LTR	NULL
activity	NULL
by	NULL
cyclosporin	NULL
A	NULL
(	NULL
Tong-Starksen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
NFAT-1	NULL
binding	NULL
sites	NULL
are	NULL
not	NULL
likely	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
HIV-LTR	NULL
activation	NULL
since	NULL
deletion	NULL
of	NULL
these	NULL
sites	NULL
still	NULL
allows	NULL
HIV-LTR	NULL
to	NULL
be	NULL
transcriptionally	NULL
activated	NULL
(	NULL
Tong-Starksen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
calcium-mediated	NULL
signals	NULL
were	NULL
not	NULL
required	NULL
for	NULL
HIV-LTR	NULL
activation	NULL
.	NULL
``	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
a	NULL
dimerized	NULL
NFAT	NULL
-1	NULL
motif	NULL
was	NULL
shown	NULL
to	NULL
drive	NULL
transcription	NULL
from	NULL
a	NULL
minimal	NULL
(	NULL
heterologous	NULL
)	NULL
promoter	NULL
(	NULL
Durand	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
this	NULL
paper	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
NFAT	NULL
-1	NULL
has	NULL
a	NULL
role	NULL
in	NULL
HIV-LTR	NULL
activation	NULL
and	NULL
accounts	NULL
for	NULL
differential	NULL
expression	NULL
of	NULL
HIV-LTR	NULL
and	NULL
that	NULL
the	NULL
cells	NULL
in	NULL
the	NULL
dermis	NULL
that	NULL
express	NULL
HIV-LTR/tat	NULL
coincide	NULL
with	NULL
the	NULL
ones	NULL
that	NULL
exhibit	NULL
NFAT-1	NULL
activity	NULL
.	NULL

We	NULL
are	NULL
initiating	NULL
studies	NULL
to	NULL
determine	NULL
the	NULL
phenotype	NULL
of	NULL
the	NULL
NFAT-Tag	NULL
expressing	NULL
dermal	NULL
cells	NULL
.	NULL

Comparison	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
the	NULL
ones	NULL
that	NULL
express	NULL
HIV-LTR/	NULL
tat	NULL
should	NULL
provide	NULL
definite	NULL
evidence	NULL
to	NULL
support	NULL
this	NULL
model	NULL
.	NULL

We	NULL
have	NULL
developed	NULL
an	NULL
approach	NULL
to	NULL
monitor	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
single	NULL
type	NULL
of	NULL
transcriptional	NULL
activator	NULL
in	NULL
a	NULL
physiological	NULL
background	NULL
.	NULL

This	NULL
opens	NULL
the	NULL
way	NULL
to	NULL
explore	NULL
the	NULL
activity	NULL
of	NULL
NFAT-1	NULL
and	NULL
its	NULL
developmental	NULL
regulation	NULL
at	NULL
the	NULL
individual	NULL
cell	NULL
level	NULL
.	NULL

Furthermore	NULL
,	NULL
this	NULL
approach	NULL
might	NULL
be	NULL
of	NULL
general	NULL
use	NULL
to	NULL
study	NULL
other	NULL
transcriptional	NULL
activators	NULL
,	NULL
in	NULL
particular	NULL
those	NULL
which	NULL
require	NULL
activation	NULL
to	NULL
exhibit	NULL
transcriptional	NULL
activity	NULL
.	NULL

Acknowledgments-We	NULL
are	NULL
grateful	NULL
to	NULL
Mary	NULL
Vadeboncoeur	NULL
,	NULL
Peggy	NULL
Sullivan	NULL
,	NULL
and	NULL
Donna	NULL
Louie	NULL
for	NULL
assistance	NULL
with	NULL
the	NULL
preparation	NULL
of	NULL
the	NULL
transgenic	NULL
mice	NULL
and	NULL
Steve	NULL
Fiering	NULL
for	NULL
stimulating	NULL
discussions	NULL
.	NULL

REFERENCES	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
Imagawa	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
Stein	NULL
,	NULL
B.	NULL
,	NULL
Imbra	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Jonat	NULL
,	NULL
C.	NULL
,	NULL
Herrlich	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
729-739	NULL
Brunvand	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Schmidt	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263	NULL
,	NULL
18904-18910	NULL
Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Przybyla	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Biochemistry	NULL
18	NULL
,	NULL
5294-5299	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
Boyle	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Meek	NULL
,	NULL
J.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
54	NULL
,	NULL
541-552	NULL
Courtois	NULL
,	NULL
G.	NULL
,	NULL
Morgan	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Campbell	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Fourel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
288	NULL
,	NULL
688-692	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
243	NULL
,	NULL
355-361	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Bush	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Morgan	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Weiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

165	NULL
,	NULL
395-407	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Shaw	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Bush	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Replogle	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Belageje	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
1715-1724	NULL
Elliott	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Lin	NULL
,	NULL
Y.	NULL
,	NULL
Mizel	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
Bleackley	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Harnish	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
and	NULL
Paetkau	NULL
,	NULL
V.	NULL
(	NULL
1984	NULL
)	NULL
Science	NULL
226	NULL
,	NULL
1439-1441	NULL
Emmel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Higgins	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Lacy	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
246	NULL
,	NULL
1617-1620	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Jr.	NULL
,	NULL
Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
III	NULL
,	NULL
Josephs	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
239	NULL
,	NULL
1150-1153	NULL
Fried	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
and	NULL
Crothers	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1981	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

9	NULL
,	NULL
6505-6526	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Shibuya	NULL
,	NULL
H.	NULL
,	NULL
Ohashi	NULL
,	NULL
T.	NULL
,	NULL
Yamanishi	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
401-407	NULL
Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1050	NULL
Guidos	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Weissman	NULL
,	NULL
I.	NULL
L.	NULL
,	NULL
and	NULL
Adkins	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

142	NULL
,	NULL
3773-3780	NULL
Gurney	NULL
,	NULL
E.	NULL
G.	NULL
,	NULL
Harrison	NULL
,	NULL
R.	NULL
O.	NULL
,	NULL
and	NULL
Fenno	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1980	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

34	NULL
,	NULL
752-763	NULL
Hogan	NULL
,	NULL
B.	NULL
L.	NULL
M.	NULL
,	NULL
Constantini	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Lacy	NULL
,	NULL
E.	NULL
(	NULL
1986	NULL
)	NULL
Manipulation	NULL
*	NULL
R.	NULL
A.	NULL
Gruters	NULL
,	NULL
S.	NULL
A.	NULL
Otto	NULL
,	NULL
B.	NULL
J.	NULL
M.	NULL
Al	NULL
,	NULL
A.	NULL
J.	NULL
Verhoeven	NULL
,	NULL
C.	NULL
L.	NULL
Verweij	NULL
,	NULL
R.	NULL
A.	NULL
W.	NULL
Van	NULL
Lier	NULL
,	NULL
and	NULL
F.	NULL
Miedema	NULL
,	NULL
unpublished	NULL
observa-tion	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san§	NULL
4q	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
duy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
NFAT-1	NULL
Transcriptional	NULL
Activity	NULL
in	NULL
Transgenic	NULL
Mice	NULL
of	NULL
the	NULL
Mouse	NULL
Embryo	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
Hoyos	NULL
,	NULL
B.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bithnlein	NULL
,	NULL
E.	NULL
,	NULL
Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
244	NULL
,	NULL
457-460	NULL
Imboden	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Stobo	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1985	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

161	NULL
,	NULL
446-456	NULL
Jung	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Gallatin	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Weissman	NULL
,	NULL
I.	NULL
L.	NULL
,	NULL
and	NULL
Dailey	NULL
,	NULL
M.	NULL
O	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

141	NULL
,	NULL
4110-4117	NULL
Kronke	NULL
,	NULL
M.	NULL
,	NULL
Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Depper	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Arya	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
,	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Waldmann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1984	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

81	NULL
,	NULL
5214-5218	NULL
Lanier	NULL
,	NULL
L.	NULL
,	NULL
Warner	NULL
,	NULL
N.	NULL
L.	NULL
,	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

153	NULL
,	NULL
998-1003	NULL
Lee	NULL
,	NULL
W.	NULL
,	NULL
Mitchell	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
741-752	NULL
Leo	NULL
,	NULL
O.	NULL
,	NULL
Foo	NULL
,	NULL
M.	NULL
,	NULL
Sachs	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
and	NULL
Bluestone	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
1874-1378	NULL
Melton	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Krieg	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Rebagliati	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Maniatis	NULL
,	NULL
T.	NULL
,	NULL
Zinn	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Green	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1984	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

12	NULL
,	NULL
7035-7056	NULL
Mitchell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
245	NULL
,	NULL
371-378	NULL
Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
326	NULL
,	NULL
711-713	NULL
Nabel	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
Gorka	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
2934-2938	NULL
Nelson	NULL
,	NULL
C.	NULL
,	NULL
Albert	NULL
,	NULL
V.	NULL
R.	NULL
,	NULL
Elsholtz	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Lu	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Rosenfeld	NULL
,	NULL
M.	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
239	NULL
,	NULL
1400-1405	NULL
Ohlsson	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Edlund	NULL
,	NULL
T.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
45	NULL
,	NULL
35-44	NULL
Paige	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Kincade	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
and	NULL
Ralph	NULL
,	NULL
P.	NULL
(	NULL
1978	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

121	NULL
,	NULL
641-647	NULL
Pierce	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Lenardo	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U	NULL
.	NULL

S	NULL
,	NULL
A	NULL
.	NULL

85	NULL
,	NULL
1482-1486	NULL
Ptashne	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
385	NULL
,	NULL
683-689	NULL
Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
III	NULL
,	NULL
Sambucetti	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
Distel	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Spiegelman	NULL
,	NULL
B.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
52	NULL
,	NULL
471-480	NULL
Reed	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Alpers	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Nowell	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
and	NULL
Hoover	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1986	NULL
)	NULL
15795	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
3982-3986	NULL
Sanger	NULL
,	NULL
F.	NULL
,	NULL
Nicklen	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Coulson	NULL
,	NULL
A.	NULL
R.	NULL
(	NULL
1977	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U	NULL
.	NULL

8	NULL
.	NULL

A	NULL
.	NULL

74	NULL
,	NULL
5463-5467	NULL
Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
921-928	NULL
Serfling	NULL
,	NULL
E.	NULL
,	NULL
Barthelm	NULL
@	NULL
s	NULL
,	NULL
R.	NULL
,	NULL
Pfeuffer	NULL
,	NULL
L.	NULL
,	NULL
Schenk	NULL
,	NULL
B.	NULL
,	NULL
Zarius	NULL
,	NULL
S.	NULL
,	NULL
Swoboda	NULL
,	NULL
R.	NULL
,	NULL
Mercurio	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
465-473	NULL
Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
Utz	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Toole	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Emmel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
202-205	NULL
Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Bressler	NULL
,	NULL
P.	NULL
,	NULL
Holbrook	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Norris	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Kamoun	NULL
,	NULL
M.	NULL
,	NULL
Kant	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6	NULL
,	NULL
3042-3049	NULL
Tong-Starksen	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Luciw	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Peterlin	NULL
,	NULL
B.	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

142	NULL
,	NULL
702-709	NULL
Truneh	NULL
,	NULL
A.	NULL
,	NULL
Albert	NULL
,	NULL
F.	NULL
,	NULL
Golstein	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Schmitt-Verhulst	NULL
,	NULL
A.	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
Nature	NULL
313	NULL
,	NULL
318-321	NULL
Ullman	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Northorp	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8	NULL
,	NULL
421-452	NULL
Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
de	NULL
Vries	NULL
,	NULL
C.	NULL
J.	NULL
M.	NULL
,	NULL
Distel	NULL
,	NULL
B.	NULL
,	NULL
van	NULL
Zonneveld	NULL
,	NULL
A.-J	NULL
.	NULL

,	NULL
Geurts	NULL
van	NULL
Kessel	NULL
,	NULL
A.	NULL
,	NULL
van	NULL
Mourik	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Pannekoek	NULL
,	NULL
H.	NULL
(	NULL
1985	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

13	NULL
,	NULL
4699-4717	NULL
Vogel	NULL
,	NULL
J.	NULL
,	NULL
Hinrichs	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Reynolds	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
Luciw	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Jay	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
606-611	NULL
Weiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Stobo	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

160	NULL
,	NULL
1284-1299	NULL
Weiss	NULL
,	NULL
A.	NULL
,	NULL
Imboden	NULL
,	NULL
J.	NULL
,	NULL
Shoback	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Stobo	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

81	NULL
,	NULL
4169-4173	NULL
Williams	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Eisenberg	NULL
,	NULL
L.	NULL
,	NULL
Burlein	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Norris	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Pancer	NULL
,	NULL
S.	NULL
,	NULL
Yao	NULL
,	NULL
D.	NULL
,	NULL
Burger	NULL
,	NULL
S.	NULL
,	NULL
Kamoun	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Kant	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

141	NULL
,	NULL
662-666	NULL
Wiskocil	NULL
,	NULL
R.	NULL
,	NULL
Weiss	NULL
,	NULL
A.	NULL
,	NULL
Imboden	NULL
,	NULL
J.	NULL
,	NULL
Kamin-Lewis	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Stobo	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

134	NULL
,	NULL
1599-1603	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
Arai	NULL
,	NULL
N.	NULL
,	NULL
Lee	NULL
,	NULL
F.	NULL
,	NULL
Rennick	NULL
,	NULL
D.	NULL
,	NULL
Mosmann	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
K-I	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

82	NULL
,	NULL
68-72	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san§	NULL
4q	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
duy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
Cell	NULL
type	NULL
specificity	NULL
and	NULL
activation	NULL
requirements	NULL
for	NULL
NFAT-1	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T-cells	NULL
)	NULL
transcriptional	NULL
activity	NULL
determined	NULL
by	NULL
a	NULL
new	NULL
method	NULL
using	NULL
transgenic	NULL
mice	NULL
to	NULL
assay	NULL
transcriptional	NULL
activity	NULL
of	NULL
an	NULL
individual	NULL
nuclear	NULL
factor	NULL
.	NULL

C	NULL
L	NULL
Verwej	NULL
,	NULL
C	NULL
Guidos	NULL
and	NULL
G	NULL
R	NULL
Crabtree	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1990	NULL
,	NULL
265:15788-15795	NULL
.	NULL

Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/265/26/15788	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
0	NULL
references	NULL
,	NULL
0	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
5788.	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
san	NULL
$	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyg	NULL
wo	NULL
;	NULL
popeoumog	NULL

